[House Report 117-381]
[From the U.S. Government Publishing Office]


117th Congress    }                                   {    Report
                        HOUSE OF REPRESENTATIVES
 2d Session       }                                   {    117-381

======================================================================

 
PROVIDING FOR CONSIDERATION OF THE BILL (H.R. 4176) TO IMPROVE FEDERAL 
   POPULATION SURVEYS BY REQUIRING THE COLLECTION OF VOLUNTARY, SELF-
  DISCLOSED INFORMATION ON SEXUAL ORIENTATION AND GENDER IDENTITY IN 
CERTAIN SURVEYS, AND FOR OTHER PURPOSES; PROVIDING FOR CONSIDERATION OF 
   THE BILL (H.R. 5585) TO ESTABLISH THE ADVANCED RESEARCH PROJECTS 
 AGENCY-HEALTH, AND FOR OTHER PURPOSES; PROVIDING FOR CONSIDERATION OF 
    THE BILL (H.R. 7666) TO AMEND THE PUBLIC HEALTH SERVICE ACT TO 
 REAUTHORIZE CERTAIN PROGRAMS RELATING TO MENTAL HEALTH AND SUBSTANCE 
     USE DISORDERS, AND FOR OTHER PURPOSES; AND FOR OTHER PURPOSES

                                _______
                                

   June 21, 2022.--Referred to the House Calendar and ordered to be 
                                printed

                                _______
                                

                Ms. Ross, from the Committee on Rules, 
                        submitted the following

                              R E P O R T

                      [To accompany H. Res. 1191]

    The Committee on Rules, having had under consideration 
House Resolution 1191, by a record vote of 9 to 4, report the 
same to the House with the recommendation that the resolution 
be adopted.

                SUMMARY OF PROVISIONS OF THE RESOLUTION

    The resolution provides for consideration of H.R. 4176, the 
LGBTQI+ Data Inclusion Act, under a structured rule. The 
resolution provides one hour of general debate equally divided 
and controlled by the chair and ranking minority member of the 
Committee on Oversight and Reform or their designees. The 
resolution waives all points of order against consideration of 
the bill. The resolution provides that an amendment in the 
nature of a substitute consisting of the text of Rules 
Committee Print 117-52, modified by the amendment printed in 
part A of this report, shall be considered as adopted and the 
bill, as amended, shall be considered as read. The resolution 
waives all points of order against provisions in the bill, as 
amended.
    The resolution makes in order only those further amendments 
to H.R. 4176 printed in part B of this report. Each such 
amendment may be offered only in the order printed in this 
report, may be offered only by a Member designated in this 
report, shall be considered as read, shall be debatable for the 
time specified in the report equally divided and controlled by 
the proponent and an opponent, shall not be subject to 
amendment, and shall not be subject to a demand for division of 
the question. The resolution waives all points of order against 
the amendments printed in part B of the report. The resolution 
provides for one motion to recommit. The resolution provides 
for consideration of H.R. 5585, the Advanced Research Projects 
Agency--Health Act, under a structured rule. The resolution 
provides one hour of general debate on the bill equally divided 
and controlled by the chair and ranking minority member of the 
Committee on Energy and Commerce or their designees. The 
resolution waives all points of order against consideration of 
the bill. The resolution provides that the amendment in the 
nature of a substitute recommended by the Committee on Energy 
and Commerce now printed in the bill shall be considered as 
adopted and the bill, as amended, shall be considered as read. 
The resolution waives all points of order against provisions in 
the bill, as amended. The resolution makes in order the further 
amendment to H.R. 5585 printed in part C of this report, if 
offered by the Member designated in this report, which shall be 
considered as read, shall be debatable for the time specified 
in the report equally divided and controlled by the proponent 
and an opponent, and shall not be subject to a demand for 
division of the question. The resolution waives all points of 
order against the amendment printed in part C of this report. 
The resolution provides one motion to recommit. The resolution 
also provides for consideration of H.R. 7666, the Restoring 
Hope for Mental Health and Well-Being Act of 2022, under a 
structured rule. The resolution provides one hour of general 
debate on the bill equally divided and controlled by the chair 
and ranking minority member of the Committee on Energy and 
Commerce or their designees. The resolution waives all points 
of order against consideration of the bill. The resolution 
provides that an amendment in the nature of a substitute 
consisting of the text of Rules Committee Print 117-51, 
modified by the amendment printed in part D of this report, 
shall be considered as adopted and the bill, as amended, shall 
be considered as read. The resolution waives all points of 
order against provisions in the bill, as amended. The 
resolution provides that following debate, each further 
amendment printed in part E of this report not earlier 
considered as part of amendments en bloc pursuant to section 6 
shall be considered only in the order printed in this report, 
may be offered only by a Member designated in this report, 
shall be considered as read, shall be debatable for the time 
specified in this report equally divided and controlled by the 
proponent and an opponent, may be withdrawn by the proponent at 
any time before the question is put thereon, shall not be 
subject to amendment, and shall not be subject to a demand for 
division of the question. Section 6 of the resolution provides 
that at any time after debate the chair of the Committee on 
Energy and Commerce or his designee may offer amendments en 
bloc consisting of further amendments printed in part E this 
report not earlier disposed of. Amendments en bloc shall be 
considered as read, shall be debatable for 20 minutes equally 
divided and controlled by the chair and ranking minority member 
of the Committee on Energy and Commerce or their designees, 
shall not be subject to amendment, and shall not be subject to 
a demand for division of the question. The resolution waives 
all points of order against the amendments printed in part E of 
this report and amendments en bloc described in section 6 of 
the resolution. The resolution provides one motion to recommit. 
The resolution provides that House Resolution 188, agreed to 
March 8, 2021 (as most recently amended by House Resolution 
1170, agreed to June 14, 2022), is amended by striking ``June 
22, 2022'' each place it appears and inserting (in each 
instance) ``July 13, 2022''. The resolution provides that 
proceedings may be postponed through July 15, 2022, on measures 
that were the object of motions to suspend the rules on the 
legislative days of June 21, 2022, June 22, 2022, June 23, 
2022, or June 24, 2022, and on which the yeas and nays were 
ordered.

                         EXPLANATION OF WAIVERS

    The waiver of all points of order against consideration of 
H.R. 4176 includes a waiver of clause 3(d)(1) of rule XIII of 
the Congressional Budget Act, which requires the inclusion of 
committee cost estimate in a committee report. A CBO cost 
estimate on H.R. 4176 was not available at the time the 
Committee on the Oversight and Reform filed its report.
    Although the resolution waives all points of order against 
provisions in H.R. 4176, as amended, the Committee is not aware 
of any points of order. The waiver is prophylactic in nature.
    Although the resolution waives all points of order against 
the amendments to H.R. 4176 printed in part B of this report, 
the Committee is not aware of any points of order. The waiver 
is prophylactic in nature.
    Although the resolution waives all points of order against 
consideration of H.R. 5585, the Committee is not aware of any 
points of order. The waiver is prophylactic in nature.
    The waiver of all points of order against provisions in 
H.R. 5585, as amended, includes a waiver of clause 4 of rule 
XXI, which prohibits reporting a bill carrying an appropriation 
from a committee not having jurisdiction to report an 
appropriation.
    Although the resolution waives all points of order against 
the amendment to H.R. 5585 printed in part C of this report, 
the Committee is not aware of any points of order. The waiver 
is prophylactic in nature.
    The waiver of all points of order against consideration of 
H.R. 7666 includes waivers of the following:
    --Clause 10 of rule XXI, which prohibits consideration of a 
measure that has a net effect of increasing the deficit or 
reducing the surplus over the five- or 10-year period; however, 
the budgetary effects of the bill are fully offset over the 10-
year period.
    --Section 302(f) of the Congressional Budget Act, which 
prohibits consideration of a bill if it has the net effect of 
increasing mandatory spending over the five- or ten-year 
period.
    The waiver of all points of order against provisions in 
H.R. 7666, as amended, includes waivers of the following:
    --Clause 4 of rule XXI, which prohibits reporting a bill 
carrying an appropriation from a committee not having 
jurisdiction to report an appropriation.
    --Clause 5(a) of rule XXI, which prohibits a bill or joint 
resolution carrying a tax or tariff measure from being reported 
by a committee not having jurisdiction to report tax or tariff 
measures.
    Although the resolution waives all points of order against 
the amendments to H.R. 7666 printed in part E of this report 
and amendments en bloc described in section 6 of the 
resolution, the Committee is not aware of any points of order. 
The waiver is prophylactic in nature.

                            COMMITTEE VOTES

    The results of each record vote on an amendment or motion 
to report, together with the names of those voting for and 
against, are printed below:

Rules Committee record vote No. 240

    Motion by Mr. Cole to add language to the rule that would 
eliminate the ability to vote remotely by proxy. Defeated: 4-9

----------------------------------------------------------------------------------------------------------------
                Majority Members                      Vote               Minority Members               Vote
----------------------------------------------------------------------------------------------------------------
Mrs. Torres.....................................          Nay   Mr. Cole..........................          Yea
Mr. Perlmutter..................................          Nay   Mr. Burgess.......................          Yea
Mr. Raskin......................................          Nay   Mr. Reschenthaler.................          Yea
Ms. Scanlon.....................................          Nay   Mrs. Fischbach....................          Yea
Mr. Morelle.....................................          Nay
Mr. DeSaulnier..................................          Nay
Ms. Ross........................................          Nay
Mr. Neguse......................................          Nay
Mr. McGovern, Chairman..........................          Nay
----------------------------------------------------------------------------------------------------------------

Rules Committee record vote No. 241

    Motion by Mr. Burgess to amend the rule to H.R. 5585 to 
make in order amendment #2, offered by Rep. Burgess (TX), which 
would ensure that nothing in this Act or the amendments made by 
this Act shall be construed to impede or interfere in any way 
with the innovation, development, or distribution of 
transformative health technologies, including diagnostic tests 
for early disease detection and intervention. Defeated: 4-9

----------------------------------------------------------------------------------------------------------------
                Majority Members                      Vote               Minority Members               Vote
----------------------------------------------------------------------------------------------------------------
Mrs. Torres.....................................          Nay   Mr. Cole..........................          Yea
Mr. Perlmutter..................................          Nay   Mr. Burgess.......................          Yea
Mr. Raskin......................................          Nay   Mr. Reschenthaler.................          Yea
Ms. Scanlon.....................................          Nay   Mrs. Fischbach....................          Yea
Mr. Morelle.....................................          Nay
Mr. DeSaulnier..................................          Nay
Ms. Ross........................................          Nay
Mr. Neguse......................................          Nay
Mr. McGovern, Chairman..........................          Nay
----------------------------------------------------------------------------------------------------------------

Rules Committee record vote No. 242

    Motion by Ms. Ross to report the rule. Adopted: 9-4

----------------------------------------------------------------------------------------------------------------
                Majority Members                      Vote               Minority Members               Vote
----------------------------------------------------------------------------------------------------------------
Mrs. Torres.....................................          Yea   Mr. Cole..........................          Nay
Mr. Perlmutter..................................          Yea   Mr. Burgess.......................          Nay
Mr. Raskin......................................          Yea   Mr. Reschenthaler.................          Nay
Ms. Scanlon.....................................          Yea   Mrs. Fischbach....................          Nay
Mr. Morelle.....................................          Yea
Mr. DeSaulnier..................................          Yea
Ms. Ross........................................          Yea
Mr. Neguse......................................          Yea
Mr. McGovern, Chairman..........................          Yea
----------------------------------------------------------------------------------------------------------------

 SUMMARY OF THE AMENDMENT TO H.R. 4176 IN PART A CONSIDERED AS ADOPTED

    1. Maloney, Carolyn (NY): Adds a finding and makes 
technical and conforming changes to the bill.

     SUMMARY OF THE AMENDMENTS TO H.R. 4176 IN PART B MADE IN ORDER

    1. Jackson Lee (TX): Requires a report to Congress from the 
Comptroller General about the impact of the implementation of 
this Act on the provision of services to persons according to 
their gender identity, sexual orientation, and variations in 
sex characteristics. (10 minutes)
    2. Maloney, Sean (NY): Clarifies that when applicable, 
federal surveys should gather information from a knowledgeable 
proxy of a deceased LGBTQI+ individual. (10 minutes)
    3. Tlaib (MI): Requires agencies collecting information 
through a covered survey to establish data standards and 
protocols for anonymizing data collected and destroying 
personally-identifiable information at the appropriate time, 
which cannot be later than 3 years after the date that the 
information was collected. (10 minutes)

     SUMMARY OF THE AMENDMENT TO H.R. 5585 IN PART C MADE IN ORDER

    1. Eshoo (CA), Guthrie (KY): Clarifies organizational 
structure of offices within ARPA-H, limits the amount of 
administrative funding that may be used to operate ARPA-H to 
15%, removes the requirement of Senate confirmation of 
Director, and clarifies ARPA-H's leasing authority. (10 
minutes)

 SUMMARY OF THE AMENDMENT TO H.R. 7666 IN PART D CONSIDERED AS ADOPTED

    1. Pallone (NJ), McMorris Rodgers (WA): Makes technical 
changes and adds provisions from H.R. 7233 as reported out of 
the Committee on Energy and Commerce. Includes provisions to 
increase transparency of pharmacy benefit managers for plan 
sponsors related to prescription drug spending and requires NIH 
to examine the effects of modern technology and multimedia on 
youth.

     SUMMARY OF THE AMENDMENTS TO H.R. 7666 IN PART E MADE IN ORDER

    1. Bera (CA), Fitzpatrick (PA): Adds the House passed 
Helping Emergency Responders Overcome (HERO) Act, which 
establishes a series of programs relating to the behavioral 
health of law enforcement officers, first responders, 9-1-1 
operators, and other public safety officers and health care 
providers. (10 minutes)
    2. Davis, Rodney (IL), Bilirakis (FL), O'Halleran (AZ), 
Wagner (MO), Kuster (NH): Adds the text of HR 2355, the Opioid 
Prescription Verification Act of 2021, which encourages the 
expanded use of electronic prescribing for opioids similar to 
the mandate for Medicare Part D opioid prescriptions under 
current law. Incentivize states to maintain and fully utilize 
prescription drug monitoring programs (PDMP) and requires the 
U.S. Department of Health and Human Services (HHS) to work with 
the CDC, DEA, and FDA to offer materials and guidance to 
pharmacists on how to verify the identity patients to help 
facilitate safe and responsible opioid prescriptions. (10 
minutes)
    3. Dean (PA), Spartz (IN), Scanlon (PA), Fitzpatrick (PA): 
Increases the time limit for health care providers to use and 
hold long-acting injectable (LAI) buprenorphine, if received 
through a specialty pharmacy, from 14 to 60 days. (10 minutes)
    4. Demings (FL): Requires a report on the available mental 
health and stress related resources or programs that are 
available to law enforcement officers. The report shall include 
additional legislative tools and authorities that may be 
helpful or necessary to assist in assessing, monitoring, and 
improving the mental health of law enforcement officers. (10 
minutes)
    5. Feenstra (IA): Requires the Behavioral Health Crisis 
Coordinating Office to include the Veterans Crisis Line as an 
entity to provide rapid post-crisis follow-up care. (10 
minutes)
    6. Ferguson (GA), Burgess (TX), Pappas (NH), Carter, Buddy 
(GA), Costa (CA), Fitzpatrick (PA), McBath (GA): Requires the 
Department of Health and Human Services (HHS) to develop best 
practices for establishing behavioral intervention teams in 
educational settings. (10 minutes)
    7. Gottheimer (NJ): Includes veterans as an eligible group 
for mental health and substance abuse care. (10 minutes)
    8. Griffith (VA): Sets January 1, 2024 as date of 
applicability for Sec. 262 to allow states time to review and 
update state law, if desired. (10 minutes)
    9. Joyce, David (OH): Requires the Department of Defense to 
carry out a two-year pilot program aimed at preventing suicides 
amongst active duty members of the Armed Forces by pre-
downloading resources onto smart devices issued to members of 
the Armed Forces and to provide training on the use of these 
resources. (10 minutes)
    10. Katko (NY), Napolitano (CA), Beyer (VA), Raskin (MD), 
Cardenas (CA), Fitzpatrick (PA): Adds the House-passed Suicide 
Prevention Lifeline Improvement Act, which includes enhanced 
funding for the National Suicide Prevention Lifeline, 
authorization for HHS to develop and implement an enhanced 
quality assurance plan for the suicide prevention hotline, 
improved data sharing with the CDC, and a pilot program for 
innovative technologies for suicide prevention. (10 minutes)
    11. Kim (NJ), Davids (KS): Adds the text of the Synthetic 
Opioid Danger Awareness Act, which requires HHS to conduct a 
public education campaign about synthetic opioids (including 
fentanyl and its analogues), disseminate information about 
synthetic opioids to health care providers, and develop a 
training guide and webinar for first responders and other 
individuals at high risk of exposure to synthetic opioids that 
details measures to prevent exposure. (10 minutes)
    12. McKinley (WV), Dingell (MI): Amends the Controlled 
Substances Act to clarify the process for registrants to 
exercise due diligence upon discovering a suspicious order. (10 
minutes)
    13. Moore (WI): Add appropriate state, local, and tribal 
public officials administering programs that serve low-income 
pregnant and postpartum individuals to the list of entities 
that the Secretary should consult with in operating and 
maintaining the maternal mental health hotline. (10 minutes)
    14. Napolitano (CA), Katko (NY): Revises Project AWARE, 
which is administered by the Substance Abuse and Mental Health 
Services Administration, to provide comprehensive school-based 
mental health services, including screening, treatment, and 
outreach programs. (10 minutes)
    15. Pressley (MA): Requires HHS to administer a report to 
study rates of suicidal behaviors among children and 
adolescents with chronic illnesses, including substance use 
disorders, autoimmune disorders and heritable blood disorders 
and to submit a report to Congress on findings. (10 minutes)
    16. Reschenthaler (PA), Morelle (NY), Wild (PA), Dean (PA): 
Requires a study to determine the true costs of untreated 
serious mental illness on families, health care systems, public 
housing, and law enforcement in America. (10 minutes)
    17. Trone (MD), Armstrong (ND), Sherrill (NJ): Authorizes 
State Opioid Response (SOR) Grants and Tribal Opioid Response 
(TOR) Grants for 5 years at $1.75 billion per year, with a 5% 
set-aside for TOR. (10 minutes)

      PART A--TEXT OF AMENDMENT TO H.R. 4176 CONSIDERED AS ADOPTED

  Page 2, after line 2, insert the following:
          (5) The integrity of the Federal statistical system 
        relies on the ability of agencies to determine the 
        content of their statistical surveys based on 
        considerations of relevance, timeliness, accuracy, 
        objectivity, and ability to maintain confidentiality.
  Page 2, line 9, insert ``for statistical purposes'' after 
``survey''.
  Page 2, beginning on line 11, strike ``existing data sets to 
determine in which data sets'' and insert ``covered surveys to 
determine in which surveys''.
  Page 2, line 24 insert ``for any survey identified in 
paragraph (1)'' after ``sex characteristics''.
  Page 3, strike lines 13 through 16 and insert the following:
          (2) Waiver.--The statistical official (as described 
        in section 314 of title 5, United States Code) of each 
        agency, or the head of the agency, for any agency that 
        does not have a statistical official, may waive the 
        requirement under paragraph (1), on a case-by-case 
        basis, if the standards and policies in subsection (c) 
        can not be met, or if adding such information to the 
        survey would impair the ability of the agency to 
        preserve the utility, accuracy, or objectivity of the 
        survey while also generating relevant evidence about 
        the LGBTQI+ community.
  Page 3, beginning on line 22, strike ``(d) Applicability.--'' 
and all that follows through ``(1) Construction.--'' and insert 
``(d) Construction.--''.
  Page 4, strike lines 3 through 9.
  Page 4, line 13, after ``any individual'' insert the 
following: ``, or that is inconsistent with disclosure 
limitations established in any other law''.
  Page 5, line 16, strike ``observation or''.

         PART B--TEXT OF AMENDMENTS TO H.R. 4176 MADE IN ORDER

1. An Amendment To Be Offered by Representative Jackson Lee of Texas or 
                 Her Designee, Debatable for 10 Minutes

  Page 4, after line 9, insert the following (and redesignate 
the subsequent subsections accordingly):
  (e) Report.-- Not later than 2 years after the date of the 
enactment of this Act, the Comptroller General shall provide a 
report to Congress on the implementation of the requirements of 
this Act by agencies, including how the implementation of such 
requirements by agencies affected the provision of services to 
persons according to the gender identity, sexual orientation, 
and variations in sex characteristics of the persons.
                              ----------                              


2. An Amendment To Be Offered by Representative Maloney of New York or 
                 His Designee, Debatable for 10 Minutes

  Page 4, line 22, insert after ``proxy'' the following: 
``(including a proxy of a deceased individual, if 
applicable)''.
                              ----------                              


 3. An Amendment To Be Offered by Representative Tlaib of Michigan or 
                 Her Designee, Debatable for 10 Minutes

  Page 2, line 20, insert after ``confidentiality'' the 
following: ``, including protocols for anonymizing data 
collected and destroying personally-identifiable information at 
the appropriate time and not later than three years after the 
date on which the information is collected''.

          PART C--TEXT OF AMENDMENT TO H.R. 5585 MADE IN ORDER

1. An Amendment To Be Offered by Representative Eshoo of California or 
                 Her Designee, Debatable for 10 Minutes

  Page 3, line 13, strike ``There is established'' and insert 
the following:
          (1) In general.--There is established
  Page 3, after line 23, insert the following:
          (2) Organization.--
                  (A) In general.--There shall be within ARPA-
                H--
                          (i) an Office of the Director;
                          (ii) not more than 6 program offices; 
                        and
                          (iii) such special project offices as 
                        the Director may establish.
                  (B) Program offices dedicated to research and 
                development.--Not fewer than two-thirds of the 
                program offices of ARPA-H shall be exclusively 
                dedicated to research and development.
  Page 6, line 16, strike ``with the advice and consent of the 
Senate,''.
  Page 14, strike line 19, and all that follows through page 
16, line 6, and insert the following:
          ``(3) Utilization of lease funds.--The Director shall 
        deposit amounts of cash consideration received for a 
        lease entered into under this subsection in the 
        `Advanced Research Projects Agency for Health' account 
        as discretionary offsetting collections, and such 
        amounts shall be available only to the extent and in 
        the amounts provided in advance in appropriations 
        Acts--
                  ``(A) to cover the full costs to ARPA-H in 
                connection with the lease;
                  ``(B) for maintenance, capital 
                revitalization, and improvements of the real 
                property assets and related personal property 
                under the jurisdiction of the Director; and
                  ``(C) for maintenance, capital 
                revitalization, and improvements of the real 
                property assets and related personal property 
                at the respective center or facility of ARPA-H 
                engaged in the lease, subject to the 
                concurrence of the Director.''.
  Page 26, lines 15 through 19, amend paragraph (3) to read as 
follows:
          ``(3) not award any grants, cooperative agreements, 
        contracts, prizes, and other transactions to 
        nondomestic recipients organized under the laws of a 
        covered foreign country (as defined in section 119C of 
        the National Security Act of 1947); and
  Page 34, lines 23 and 24, strike ``There is authorized'' and 
insert the following:
          (1) In general.--To carry out this section, there is 
        authorized
  Page 35, after line 2 (but before the close quotation mark 
and second period) insert the following:
          (2) Administrative expenses.--Not more than 15 
        percent of the amounts made available to carry out this 
        section for any fiscal year may be used for 
        administrative expenses to operate ARPA-H.

      PART D--TEXT OF AMENDMENT TO H.R. 7666 CONSIDERED AS ADOPTED

  Amend section 263 to read as follows:

SEC. 263. REQUIRING PRESCRIBERS OF CONTROLLED SUBSTANCES TO COMPLETE 
                    TRAINING.

  Section 303 of the Controlled Substances Act (21 U.S.C. 823) 
is amended by adding at the end the following:
  ``(l) Required Training for Prescribers.--
          ``(1) Training required.--As a condition on 
        registration under this section to dispense controlled 
        substances in schedule II, III, IV, or V, the Attorney 
        General shall require any qualified practitioner, 
        beginning with the first applicable registration for 
        the practitioner, to meet the following:
                  ``(A) If the practitioner is a physician (as 
                defined under section 1861(r) of the Social 
                Security Act), the practitioner meets one or 
                more of the following conditions:
                          ``(i) The physician holds a board 
                        certification in addiction psychiatry 
                        or addiction medicine from the American 
                        Board of Medical Specialties.
                          ``(ii) The physician holds a board 
                        certification from the American Board 
                        of Addiction Medicine.
                          ``(iii) The physician holds a board 
                        certification in addiction medicine 
                        from the American Osteopathic 
                        Association.
                          ``(iv) The physician has, with 
                        respect to the treatment and management 
                        of patients with opioid or other 
                        substance use disorders, or the safe 
                        pharmacological management of dental 
                        pain and screening, brief intervention, 
                        and referral for appropriate treatment 
                        of patients with or at risk of 
                        developing opioid or other substance 
                        use disorders, completed not less than 
                        8 hours of training (through classroom 
                        situations, seminars at professional 
                        society meetings, electronic 
                        communications, or otherwise) that is 
                        provided by--
                                  ``(I) the American Society of 
                                Addiction Medicine, the 
                                American Academy of Addiction 
                                Psychiatry, the American 
                                Medical Association, the 
                                American Osteopathic 
                                Association, the American 
                                Dental Association, the 
                                American Association of Oral 
                                and Maxillofacial Surgeons, the 
                                American Psychiatric 
                                Association, or any other 
                                organization accredited by the 
                                Accreditation Council for 
                                Continuing Medical Education 
                                (commonly known as the `ACCME') 
                                or the Commission on Dental 
                                Accreditation;
                                  ``(II) any organization 
                                accredited by a State medical 
                                society accreditor that is 
                                recognized by the ACCME or the 
                                Commission on Dental 
                                Accreditation;
                                  ``(III) any organization 
                                accredited by the American 
                                Osteopathic Association to 
                                provide continuing medical 
                                education; or
                                  ``(IV) any organization 
                                approved by the Assistant 
                                Secretary for Mental Health and 
                                Substance Abuse, the ACCME, or 
                                the Commission on Dental 
                                Accreditation.
                          ``(v) The physician graduated in good 
                        standing from an accredited school of 
                        allopathic medicine, osteopathic 
                        medicine, dental surgery, or dental 
                        medicine in the United States during 
                        the 5-year period immediately preceding 
                        the date on which the physician first 
                        registers or renews under this section 
                        and has successfully completed a 
                        comprehensive allopathic or osteopathic 
                        medicine curriculum or accredited 
                        medical residency or dental surgery or 
                        dental medicine curriculum that 
                        included not less than 8 hours of 
                        training on--
                                  ``(I) treating and managing 
                                patients with opioid and other 
                                substance use disorders, 
                                including the appropriate 
                                clinical use of all drugs 
                                approved by the Food and Drug 
                                Administration for the 
                                treatment of a substance use 
                                disorder; or
                                  ``(II) the safe 
                                pharmacological management of 
                                dental pain and screening, 
                                brief intervention, and 
                                referral for appropriate 
                                treatment of patients with or 
                                at risk of developing opioid 
                                and other substance use 
                                disorders.
                  ``(B) If the practitioner is not a physician 
                (as defined under section 1861(r) of the Social 
                Security Act), the practitioner meets one or 
                more of the following conditions:
                          ``(i) The practitioner has completed 
                        not fewer than 8 hours of training with 
                        respect to the treatment and management 
                        of patients with opioid or other 
                        substance use disorders (through 
                        classroom situations, seminars at 
                        professional society meetings, 
                        electronic communications, or 
                        otherwise) provided by the American 
                        Society of Addiction Medicine, the 
                        American Academy of Addiction 
                        Psychiatry, the American Medical 
                        Association, the American Osteopathic 
                        Association, the American Nurses 
                        Credentialing Center, the American 
                        Psychiatric Association, the American 
                        Association of Nurse Practitioners, the 
                        American Academy of Physician 
                        Associates, or any other organization 
                        approved or accredited by the Assistant 
                        Secretary for Mental Health and 
                        Substance Abuse or the Accreditation 
                        Council for Continuing Medical 
                        Education.
                          ``(ii) The practitioner has graduated 
                        in good standing from an accredited 
                        physician assistant school or 
                        accredited school of advanced practice 
                        nursing in the United States during the 
                        5-year period immediately preceding the 
                        date on which the practitioner first 
                        registers or renews under this section 
                        and has successfully completed a 
                        comprehensive physician assistant or 
                        advanced practice nursing curriculum 
                        that included not fewer than 8 hours of 
                        training on treating and managing 
                        patients with opioid and other 
                        substance use disorders, including the 
                        appropriate clinical use of all drugs 
                        approved by the Food and Drug 
                        Administration for the treatment of a 
                        substance use disorder.
          ``(2) One-time training.--
                  ``(A) In general.--The Attorney General shall 
                not require any qualified practitioner to 
                complete the training described in clause (iv) 
                or (v) of paragraph (1)(A) or clause (i) or 
                (ii) of paragraph (1)(B) more than once.
                  ``(B) Notification.--Not later than 90 days 
                after the date of the enactment of the 
                Restoring Hope for Mental Health and Well-Being 
                Act of 2022, the Attorney General shall provide 
                to qualified practitioners a single written, 
                electronic notification of the training 
                described in clauses (iv) and (v) of paragraph 
                (1)(A) or clauses (i) and (ii) of paragraph 
                (1)(B).
          ``(3) Rule of construction.--Nothing in this 
        subsection shall be construed to preclude the use, by a 
        qualified practitioner, of training received pursuant 
        to this subsection to satisfy registration requirements 
        of a State or for some other lawful purpose.
          ``(4) Definitions.--In this section:
                  ``(A) First applicable registration.--The 
                term `first applicable registration' means the 
                first registration or renewal of registration 
                by a qualified practitioner under this section 
                that occurs on or after the date that is 180 
                days after the date of enactment of the 
                Restoring Hope for Mental Health and Well-Being 
                Act of 2022.
                  ``(B) Qualified practitioner.--In this 
                subsection, the term `qualified practitioner' 
                means a practitioner who--
                          ``(i) is licensed under State law to 
                        prescribe controlled substances; and
                          ``(ii) is not solely a 
                        veterinarian.''.

  Page 150, after line 5, insert the following:

SEC. 312. REAUTHORIZATION OF MINORITY FELLOWSHIP PROGRAM.

  Section 597(c) of the Public Health Service Act (42 U.S.C. 
290ll(c)) is amended by striking ``$12,669,000 for each of 
fiscal years 2018 through 2022'' and inserting ``$25,000,000 
for each of fiscal years 2023 through 2027''.

  At the end of title IV, add the following new subtitle:

                  Subtitle D--Media and Mental Health

SEC. 431. STUDY ON THE EFFECTS OF SMARTPHONE AND SOCIAL MEDIA USE ON 
                    ADOLESCENTS.

  (a) In General.--Not later than 1 year after the date of 
enactment of this Act, the Secretary of Health and Human 
Services shall conduct or support research on--
          (1) smartphone and social media use by adolescents; 
        and
          (2) the effects of such use on--
                  (A) emotional, behavioral, and physical 
                health and development; and
                  (B) any disparities in the mental health 
                outcomes of rural, minority, and other 
                underserved populations.
  (b) Report.--Not later than 5 years after the date of 
enactment of this Act, the Secretary of Health and Human 
Services shall submit to the Congress, and make publicly 
available, a report on the findings of research under this 
section.

SEC. 432. RESEARCH ON THE HEALTH AND DEVELOPMENT EFFECTS OF MEDIA ON 
                    INFANTS, CHILDREN, AND ADOLESCENTS.

  Subpart 7 of part C of title IV of the Public Health Service 
Act (42 U.S.C. 285g et seq.) is amended by adding at the end 
the following:

``SEC. 452H. RESEARCH ON THE HEALTH AND DEVELOPMENT EFFECTS OF MEDIA ON 
                    INFANTS, CHILDREN, AND ADOLESCENTS.

  ``(a) In General.--The Director of the National Institutes of 
Health, in coordination with or acting through the Director of 
the Institute, shall conduct and support research and related 
activities concerning the health and developmental effects of 
media on infants, children, and adolescents, which may include 
the positive and negative effects of exposure to and use of 
media, such as social media, applications, websites, 
television, motion pictures, artificial intelligence, mobile 
devices, computers, video games, virtual and augmented reality, 
and other media formats as they become available. Such research 
shall attempt to better understand the relationships between 
media and technology use and individual differences and 
characteristics of children and shall include longitudinally 
designed studies to assess the impact of media on youth over 
time. Such research shall include consideration of core areas 
of child and adolescent health and development including the 
following:
          ``(1) Cognitive.--The role and impact of media use 
        and exposure in the development of children and 
        adolescents within such cognitive areas as language 
        development, executive functioning, attention, creative 
        problem solving skills, visual and spatial skills, 
        literacy, critical thinking, and other learning 
        abilities, and the impact of early technology use on 
        developmental trajectories.
          ``(2) Physical.--The role and impact of media use and 
        exposure on children's and adolescent's physical 
        development and health behaviors, including diet, 
        exercise, sleeping and eating routines, and other areas 
        of physical development.
          ``(3) Socio-emotional.--The role and impact of media 
        use and exposure on children's and adolescents' social-
        emotional competencies, including self-awareness, self-
        regulation, social awareness, relationship skills, 
        empathy, distress tolerance, perception of social cues, 
        awareness of one's relationship with the media, and 
        decision-making, as well as outcomes such as violations 
        of privacy, perpetration of or exposure to violence, 
        bullying or other forms of aggression, depression, 
        anxiety, substance use, misuse or disorder, and 
        suicidal ideation/behavior and self-harm.
  ``(b) Developing Research Agenda.--The Director of the 
National Institutes of Health, in consultation with the 
Director of the Institute, other appropriate national research 
institutes, academies, and centers, the Trans-NIH Pediatric 
Research Consortium, and non-Federal experts as needed, shall 
develop a research agenda on the health and developmental 
effects of media on infants, children, and adolescents to 
inform research activities under subsection (a). In developing 
such research agenda, the Director may use whatever means 
necessary (such as scientific workshops and literature reviews) 
to assess current knowledge and research gaps in this area.
  ``(c) Research Program.--In coordination with the Institute 
and other national research institutes and centers, and 
utilizing the National Institutes of Health's process of 
scientific peer review, the Director of the National Institutes 
of Health shall fund an expanded research program on the health 
and developmental effects of media on infants, children, and 
adolescents.
  ``(d) Report to Congress.--Not later than 1 year after the 
date of enactment of this Act, the Director of the National 
Institutes of Health shall submit a report to Congress on the 
progress made in gathering data and expanding research on the 
health and developmental effects of media on infants, children, 
and adolescents in accordance with this section. Such report 
shall summarize the grants and research funded, by year, under 
this section.''.

  At the end of the bill, add the following new titles:

                       TITLE V--MEDICAID AND CHIP

SEC. 501. MEDICAID AND CHIP REQUIREMENTS FOR HEALTH SCREENINGS AND 
                    REFERRALS FOR ELIGIBLE JUVENILES IN PUBLIC 
                    INSTITUTIONS.

  (a) Medicaid State Plan Requirement.--Section 1902 of the 
Social Security Act (42 U.S.C. 1396a) is amended--
          (1) in subsection (a)(84)--
                  (A) in subparagraph (A), by inserting ``, 
                subject to subparagraph (D),'' after ``but'';
                  (B) in subparagraph (B), by striking ``and'' 
                at the end;
                  (C) in subparagraph (C), by adding ``and'' at 
                the end; and
                  (D) by adding at the end the following new 
                subparagraph:
                  ``(D) beginning on the first day of the first 
                calendar quarter that begins two years after 
                the date of enactment of this subparagraph, in 
                the case of individuals who are eligible 
                juveniles described in subsection (nn)(2), are 
                within 30 days of the date on which such 
                eligible juvenile is scheduled to be released 
                from a public institution following 
                adjudication, the State shall have in place a 
                plan to ensure, and in accordance with such 
                plan, provide--
                          ``(i) for, in the 30 days prior to 
                        the release of such an eligible 
                        juvenile from such public institution 
                        (or not later than one week after 
                        release from the public institution), 
                        and in coordination with such 
                        institution--
                                  ``(I) any screening or 
                                diagnostic service which meets 
                                reasonable standards of medical 
                                and dental practice, as 
                                determined by the State, or as 
                                indicated as medically 
                                necessary, in accordance with 
                                paragraphs (1)(A) and (5) of 
                                section 1905(r); and
                                  ``(II) a mental health or 
                                other behavioral health 
                                screening that is a screening 
                                service described under section 
                                1905(r)(1), or a diagnostic 
                                service described under 
                                paragraph (5) of such section, 
                                if such screening or diagnostic 
                                service was not otherwise 
                                conducted pursuant to this 
                                clause;
                          ``(ii) for, not later than one week 
                        after release from the public 
                        institution, referrals for such 
                        eligible juvenile to the appropriate 
                        care and services available under the 
                        State plan (or waiver of such plan) in 
                        the geographic region of the home or 
                        residence of such eligible juvenile, 
                        based on such screenings; and
                          ``(iii) for, following the release of 
                        such eligible juvenile from such 
                        institution, not less than 30 days of 
                        targeted case management services 
                        furnished by a provider in the 
                        geographic region of the home or 
                        residence of such eligible juvenile.''; 
                        and
          (2) in subsection (nn)(3), by striking ``(30)'' and 
        inserting ``(31)''.
  (b) Authorization of Federal Financial Participation.--The 
subdivision (A) of section 1905(a) of the Social Security Act 
(42 U.S.C. 1396d(a)) following paragraph (31) of such section 
is amended by inserting ``, or in the case of an eligible 
juvenile described in section 1902(a)(84)(D) with respect to 
the screenings, diagnostic services, referrals, and case 
management required under such subparagraph (D)'' after 
``(except as a patient in a medical institution''.
  (c) CHIP Conforming Amendments.--
          (1) Section 2103(c) of the Social Security Act (42 
        U.S.C. 1397cc(c)) is amended by adding at the end the 
        following new paragraph:
          ``(12) Required coverage of screenings, diagnostic 
        services, referrals, and case management for certain 
        inmates pre-release.--With respect to individuals 
        described in section 2110(b)(7), the State shall 
        provide screenings, diagnostic services, referrals, and 
        case management otherwise covered under the State child 
        health plan (or waiver of such plan) during the period 
        described in such section with respect to such 
        screenings, services, referrals, and case 
        management.''.
          (2) Section 2110(b) of the Social Security Act (42 
        U.S.C. 1397jj(b)) is amended--
                  (A) in paragraph (2)(A), by inserting 
                ``except as provided in paragraph (7),'' before 
                ``a child who is an inmate of a public 
                institution''; and
                  (B) by adding at the end the following new 
                paragraph:
          ``(7) Exception to exclusion of children who are 
        inmates of a public institution.--A child shall not be 
        considered to be described in paragraph (2)(A) if such 
        child is an eligible juvenile (as described in section 
        1902(a)(84)(D)) with respect to the screenings, 
        diagnostic services, referrals, and case management 
        otherwise covered under the State child health plan (or 
        waiver of such plan) during the period with respect to 
        which such screenings, services, referrals, and case 
        management is respectively required under such 
        section.''.

SEC. 502. GUIDANCE ON REDUCING ADMINISTRATIVE BARRIERS TO PROVIDING 
                    HEALTH CARE SERVICES IN SCHOOLS.

  (a) In General.--Not later than 12 months after the date of 
enactment of this Act, the Secretary of Health and Human 
Services shall issue guidance to State Medicaid agencies, 
elementary and secondary schools, and school-based health 
centers on reducing administrative barriers to such schools and 
centers furnishing medical assistance and obtaining payment for 
such assistance under titles XIX and XXI of the Social Security 
Act (42 U.S.C. 1396 et seq., 1397aa et seq.).
  (b) Contents of Guidance.--The guidance issued pursuant to 
subsection (a) shall--
          (1) include revisions to the May 2003 Medicaid 
        School-Based Administrative Claiming Guide, the 1997 
        Medicaid and Schools Technical Assistance Guide, and 
        other relevant guidance in effect on the date of 
        enactment of this Act;
          (2) provide information on payment under titles XIX 
        and XXI of the Social Security Act (42 U.S.C. 1396 et 
        seq., 1397aa et seq.) for the provision of medical 
        assistance, including such assistance provided in 
        accordance with an individualized education program or 
        under the policy described in the State Medicaid 
        Director letter on payment for services issued on 
        December 15, 2014 (#14-006);
          (3) take into account reasons why small and rural 
        local education agencies may not provide medical 
        assistance and provide information on best practices to 
        encourage such agencies to provide such assistance; and
          (4) include best practices and examples of methods 
        that State Medicaid agencies and local education 
        agencies have used to pay for, and increase the 
        availability of, medical assistance.
  (c) Definitions.--In this Act:
          (1) Individualized education program.--The term 
        ``individualized education program'' has the meaning 
        given such term in section 602(14) of the Individuals 
        with Disabilities Education Act (20 U.S.C. 1401(14)).
          (2) School-based health center.--The term ``school-
        based health center'' has the meaning given such term 
        in section 2110(c)(9) of the Social Security Act (42 
        U.S.C. 1397jj(c)(9)), and includes an entity that 
        provides Medicaid-covered services in school-based 
        settings for which Federal financial participation is 
        permitted.

SEC. 503. GUIDANCE TO STATES ON SUPPORTING PEDIATRIC BEHAVIORAL HEALTH 
                    SERVICES UNDER MEDICAID AND CHIP.

  Not later than 18 months after the date of enactment of this 
Act, the Secretary of Health and Human Services shall issue 
guidance to States on how to expand the provision of, and 
access to, behavioral health services, including mental health 
services, for children covered under State plans (or waivers of 
such plans) under title XIX of the Social Security Act (42 
U.S.C. 1396 et seq.), or State child health plans (or waivers 
of such plans) under title XXI of such Act (42 U.S.C. 1397aa et 
seq.), including a description of best practices for--
          (1) expanding access to such services;
          (2) expanding access to such services in underserved 
        communities;
          (3) flexibilities that States may offer for pediatric 
        hospitals and other pediatric behavioral health 
        providers to expand access to services; and
          (4) recruitment and retention of providers of such 
        services.

SEC. 504. ENSURING CHILDREN RECEIVE TIMELY ACCESS TO CARE.

  (a) Guidance to States on Flexibilities to Ensure Provider 
Capacity to Provide Pediatric Behavioral Health, Including 
Mental Health, Crisis Care.--Not later than 18 months after the 
date of enactment of this Act, the Secretary of Health and 
Human Services shall provide guidance to States on existing 
flexibilities under State plans (or waivers of such plans) 
under title XIX of the Social Security Act (42 U.S.C. 1396 et 
seq.), or State child health plans under title XXI of such Act 
(42 U.S.C. 1397aa et seq.), to support children experiencing a 
behavioral health crisis or in need of intensive behavioral 
health, including mental health, services.
  (b) Ensuring Consistent Review and State Implementation of 
Early and Periodic Screening, Diagnostic, and Treatment 
Services.--Section 1905(r) of the Social Security Act (42 
U.S.C. 1396d(r)) is amended by adding at the end the following: 
``Not later than January 1, 2025, and every 5 years thereafter, 
the Secretary shall review implementation of the requirements 
of this subsection by States, including such requirements 
relating to services provided by managed care organizations, 
prepaid inpatient health plans, prepaid ambulatory health 
plans, and primary care case managers, to identify and 
disseminate best practices for ensuring comprehensive coverage 
of services, to identify gaps and deficiencies in meeting 
Federal requirements, and to provide guidance to States on 
addressing identified gaps and disparities and meeting Federal 
coverage requirements in order to ensure children have access 
to health services.''.

SEC. 505. STRATEGIES TO INCREASE ACCESS TO TELEHEALTH UNDER MEDICAID 
                    AND CHIP.

  Not later than 1 year after the date of the enactment of this 
Act, and in the event updates are available, once every five 
years thereafter, the Secretary of Health and Human Services 
shall update guidance issued by the Centers for Medicare & 
Medicaid Services to States, the State Medicaid & CHIP 
Telehealth Toolkit, or any successor guidance, to describe 
strategies States may use to overcome existing barriers and 
increase access to telehealth services under the Medicaid 
program under title XIX of the Social Security Act (42 U.S.C. 
1396 et seq.) and the Children's Health Insurance Program under 
title XXI of such Act (42 U.S.C. 1397aa et seq.). Such updated 
guidance shall include examples of and promising practices 
regarding--
          (1) telehealth delivery of covered services;
          (2) recommended voluntary billing codes, modifiers, 
        and place-of-service designations for telehealth and 
        other virtual health care services;
          (3) strategies States can use for the simplification 
        or alignment of provider credentialing and enrollment 
        protocols with respect to telehealth across States, 
        State Medicaid plans under title XIX, State child 
        health plans under title XXI, Medicaid managed care 
        organizations, prepaid inpatient health plans, prepaid 
        ambulatory health plans, and primary care case 
        managers, including during national public health 
        emergencies; and
          (4) strategies States can use to integrate telehealth 
        and other virtual health care services into value-based 
        health care models.

SEC. 506. REMOVAL OF LIMITATIONS ON FEDERAL FINANCIAL PARTICIPATION FOR 
                    INMATES WHO ARE ELIGIBLE JUVENILES PENDING 
                    DISPOSITION OF CHARGES.

  (a) Medicaid.--
          (1) In general.--The subdivision (A) of section 
        1905(a) of the Social Security Act (42 U.S.C. 1396d(a)) 
        following paragraph (31) of such section, as amended by 
        section 501(b), is further amended by inserting ``, or, 
        at the option of the State, for an individual who is an 
        eligible juvenile (as defined in section 1902(nn)(2)), 
        while such individual is an inmate of a public 
        institution (as defined in section 1902(nn)(3)) pending 
        disposition of charges'' after ``or in the case of an 
        eligible juvenile described in section 1902(a)(84)(D) 
        with respect to the screenings, diagnostic services, 
        referrals, and case management required under such 
        subparagraph (D)''.
          (2) Conforming.--Section 1902(a)(84)(A) of the Social 
        Security Act (42 U.S.C. 1396a(a)(84)(A)) is amended by 
        inserting ``(or in the case of a State electing the 
        option described in the subdivision (A) following 
        paragraph (31) of section 1905(a), during such period 
        beginning after the disposition of charges with respect 
        to such individual)'' after ``is such an inmate''.
  (b) CHIP.--Section 2110(b)(7) of the Social Security Act (42 
U.S.C. 13977jj(b)(7)), as added by section 501(c)(2)(B), is 
further amended by inserting ``or, at the option of the State, 
for an individual who is a juvenile, while such individual is 
an inmate of a public institution pending disposition of 
charges'' after ``if such child is an eligible juvenile (as 
described in section 1902(a)(84)(D)) with respect to 
screenings, diagnostic services, referrals, and case management 
otherwise covered under the State child health plan (or waiver 
of such plan)''.
  (c) Effective Date.--The amendments made by this section 
shall take effect on the first day of the first calendar 
quarter that begins after the date that is 18 months after the 
date of enactment of this Act and shall apply to items and 
services furnished for periods beginning on or after such date.

                   TITLE VI--MISCELLANEOUS PROVISIONS

SEC. 601. DETERMINATION OF BUDGETARY EFFECTS.

  The budgetary effects of this Act, for the purpose of 
complying with the Statutory Pay-As-You-Go Act of 2010, shall 
be determined by reference to the latest statement titled 
``Budgetary Effects of PAYGO Legislation'' for this Act, 
submitted for printing in the Congressional Record by the 
Chairman of the House Budget Committee, provided that such 
statement has been submitted prior to the vote on passage.

SEC. 602. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

  (a) PHSA.--Title XXVII of the Public Health Service Act (42 
U.S.C. 300gg et seq.) is amended--
          (1) in part D (42 U.S.C. 300gg-111 et seq.), by 
        adding at the end the following new section:

``SEC. 2799A-11. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

  ``(a) In General.--For plan years beginning on or after 
January 1, 2024, a group health plan or health insurance issuer 
offering group health insurance coverage or an entity or 
subsidiary providing pharmacy benefits management services on 
behalf of such a plan or issuer shall not enter into a contract 
with a drug manufacturer, distributor, wholesaler, 
subcontractor, rebate aggregator, or any associated third party 
that limits the disclosure of information to plan sponsors in 
such a manner that prevents the plan or issuer, or an entity or 
subsidiary providing pharmacy benefits management services on 
behalf of a plan or issuer, from making the reports described 
in subsection (b).
  ``(b) Reports.--
          ``(1) In general.--For plan years beginning on or 
        after January 1, 2024, not less frequently than once 
        every 6 months, a health insurance issuer offering 
        group health insurance coverage or an entity providing 
        pharmacy benefits management services on behalf of a 
        group health plan or an issuer providing group health 
        insurance coverage shall submit to the plan sponsor (as 
        defined in section 3(16)(B) of the Employee Retirement 
        Income Security Act of 1974) of such group health plan 
        or health insurance coverage a report in accordance 
        with this subsection and make such report available to 
        the plan sponsor in a machine-readable format. Each 
        such report shall include, with respect to the 
        applicable group health plan or health insurance 
        coverage--
                  ``(A) as applicable, information collected 
                from drug manufacturers by such issuer or 
                entity on the total amount of copayment 
                assistance dollars paid, or copayment cards 
                applied, that were funded by the drug 
                manufacturer with respect to the participants 
                and beneficiaries in such plan or coverage;
                  ``(B) a list of each drug covered by such 
                plan, issuer, or entity providing pharmacy 
                benefit management services that was dispensed 
                during the reporting period, including, with 
                respect to each such drug during the reporting 
                period--
                          ``(i) the brand name, chemical 
                        entity, and National Drug Code;
                          ``(ii) the number of participants and 
                        beneficiaries for whom the drug was 
                        filled during the plan year, the total 
                        number of prescription fills for the 
                        drug (including original prescriptions 
                        and refills), and the total number of 
                        dosage units of the drug dispensed 
                        across the plan year, including whether 
                        the dispensing channel was by retail, 
                        mail order, or specialty pharmacy;
                          ``(iii) the wholesale acquisition 
                        cost, listed as cost per days supply 
                        and cost per pill, or in the case of a 
                        drug in another form, per dose;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries on such drug, including 
                        participant and beneficiary spending 
                        through copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for any drug for which gross 
                        spending of the group health plan or 
                        health insurance coverage exceeded 
                        $10,000 during the reporting period--
                                  ``(I) a list of all other 
                                drugs in the same therapeutic 
                                category or class, including 
                                brand name drugs and biological 
                                products and generic drugs or 
                                biosimilar biological products 
                                that are in the same 
                                therapeutic category or class 
                                as such drug; and
                                  ``(II) the rationale for 
                                preferred formulary placement 
                                of such drug in that 
                                therapeutic category or class, 
                                if applicable;
                  ``(C) a list of each therapeutic category or 
                class of drugs that were dispensed under the 
                health plan or health insurance coverage during 
                the reporting period, and, with respect to each 
                such therapeutic category or class of drugs, 
                during the reporting period--
                          ``(i) total gross spending by the 
                        plan, before manufacturer rebates, 
                        fees, or other manufacturer 
                        remuneration;
                          ``(ii) the number of participants and 
                        beneficiaries who filled a prescription 
                        for a drug in that category or class;
                          ``(iii) if applicable to that 
                        category or class, a description of the 
                        formulary tiers and utilization 
                        mechanisms (such as prior authorization 
                        or step therapy) employed for drugs in 
                        that category or class;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries, including participant 
                        and beneficiary spending through 
                        copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for each therapeutic category 
                        or class under which 3 or more drugs 
                        are included on the formulary of such 
                        plan or coverage--
                                  ``(I) the amount received, or 
                                expected to be received, from 
                                drug manufacturers in rebates, 
                                fees, alternative discounts, or 
                                other remuneration--
                                          ``(aa) that has been 
                                        paid, or is to be paid, 
                                        by drug manufacturers 
                                        for claims incurred 
                                        during the reporting 
                                        period; or
                                          ``(bb) that is 
                                        related to utilization 
                                        of drugs, in such 
                                        therapeutic category or 
                                        class;
                                  ``(II) the total net 
                                spending, after deducting 
                                rebates, price concessions, 
                                alternative discounts or other 
                                remuneration from drug 
                                manufacturers, by the health 
                                plan or health insurance 
                                coverage on that category or 
                                class of drugs; and
                                  ``(III) the net price per 
                                course of treatment or single 
                                fill, such as a 30-day supply 
                                or 90-day supply, incurred by 
                                the health plan or health 
                                insurance coverage and its 
                                participants and beneficiaries, 
                                after manufacturer rebates, 
                                fees, and other remuneration 
                                for drugs dispensed within such 
                                therapeutic category or class 
                                during the reporting period;
                  ``(D) total gross spending on prescription 
                drugs by the plan or coverage during the 
                reporting period, before rebates and other 
                manufacturer fees or remuneration;
                  ``(E) total amount received, or expected to 
                be received, by the health plan or health 
                insurance coverage in drug manufacturer 
                rebates, fees, alternative discounts, and all 
                other remuneration received from the 
                manufacturer or any third party, other than the 
                plan sponsor, related to utilization of drug or 
                drug spending under that health plan or health 
                insurance coverage during the reporting period;
                  ``(F) the total net spending on prescription 
                drugs by the health plan or health insurance 
                coverage during the reporting period; and
                  ``(G) amounts paid directly or indirectly in 
                rebates, fees, or any other type of 
                remuneration to brokers, consultants, advisors, 
                or any other individual or firm who referred 
                the group health plan's or health insurance 
                issuer's business to the pharmacy benefit 
                manager.
          ``(2) Privacy requirements.--Health insurance issuers 
        offering group health insurance coverage and entities 
        providing pharmacy benefits management services on 
        behalf of a group health plan shall provide information 
        under paragraph (1) in a manner consistent with the 
        privacy, security, and breach notification regulations 
        promulgated under section 264(c) of the Health 
        Insurance Portability and Accountability Act of 1996, 
        and shall restrict the use and disclosure of such 
        information according to such privacy regulations.
          ``(3) Disclosure and redisclosure.--
                  ``(A) Limitation to business associates.--A 
                group health plan receiving a report under 
                paragraph (1) may disclose such information 
                only to business associates of such plan as 
                defined in section 160.103 of title 45, Code of 
                Federal Regulations (or successor regulations).
                  ``(B) Clarification regarding public 
                disclosure of information.--Nothing in this 
                section prevents a health insurance issuer 
                offering group health insurance coverage or an 
                entity providing pharmacy benefits management 
                services on behalf of a group health plan from 
                placing reasonable restrictions on the public 
                disclosure of the information contained in a 
                report described in paragraph (1), except that 
                such issuer or entity may not restrict 
                disclosure of such report to the Department of 
                Health and Human Services, the Department of 
                Labor, the Department of the Treasury, or 
                applicable State agencies.
                  ``(C) Limited form of report.--The Secretary 
                shall define through rulemaking a limited form 
                of the report under paragraph (1) required of 
                plan sponsors who are drug manufacturers, drug 
                wholesalers, or other direct participants in 
                the drug supply chain, in order to prevent 
                anti-competitive behavior.
          ``(4) Report to gao.--A health insurance issuer 
        offering group health insurance coverage or an entity 
        providing pharmacy benefits management services on 
        behalf of a group health plan shall submit to the 
        Comptroller General of the United States each of the 
        first 4 reports submitted to a plan sponsor under 
        paragraph (1) with respect to such coverage or plan, 
        and other such reports as requested, in accordance with 
        the privacy requirements under paragraph (2), the 
        disclosure and redisclosure standards under paragraph 
        (3), the standards specified pursuant to paragraph (5), 
        and such other information that the Comptroller General 
        determines necessary to carry out the study under 
        section 602(d) of the Restoring Hope for Mental Health 
        and Well-Being Act of 2022.
          ``(5) Standard format.--Not later than June 1, 2023, 
        the Secretary shall specify through rulemaking 
        standards for health insurance issuers and entities 
        required to submit reports under paragraph (4) to 
        submit such reports in a standard format.
  ``(c) Enforcement.--
          ``(1) In general.--The Secretary, in consultation 
        with the Secretary of Labor and the Secretary of the 
        Treasury, shall enforce this section.
          ``(2) Failure to provide timely information.--A 
        health insurance issuer or an entity providing pharmacy 
        benefit management services that violates subsection 
        (a) or fails to provide information required under 
        subsection (b), or a drug manufacturer that fails to 
        provide information under subsection (b)(1)(A) in a 
        timely manner, shall be subject to a civil monetary 
        penalty in the amount of $10,000 for each day during 
        which such violation continues or such information is 
        not disclosed or reported.
          ``(3) False information.--A health insurance issuer, 
        entity providing pharmacy benefit management services, 
        or drug manufacturer that knowingly provides false 
        information under this section shall be subject to a 
        civil money penalty in an amount not to exceed $100,000 
        for each item of false information. Such civil money 
        penalty shall be in addition to other penalties as may 
        be prescribed by law.
          ``(4) Procedure.--The provisions of section 1128A of 
        the Social Security Act, other than subsection (a) and 
        (b) and the first sentence of subsection (c)(1) of such 
        section shall apply to civil monetary penalties under 
        this subsection in the same manner as such provisions 
        apply to a penalty or proceeding under section 1128A of 
        the Social Security Act.
          ``(5) Waivers.--The Secretary may waive penalties 
        under paragraph (2), or extend the period of time for 
        compliance with a requirement of this section, for an 
        entity in violation of this section that has made a 
        good-faith effort to comply with this section.
  ``(d) Rule of Construction.--Nothing in this section shall be 
construed to permit a health insurance issuer, group health 
plan, or other entity to restrict disclosure to, or otherwise 
limit the access of, the Department of Health and Human 
Services to a report described in subsection (b)(1) or 
information related to compliance with subsection (a) by such 
issuer, plan, or entity.
  ``(e) Definition.--In this section, the term `wholesale 
acquisition cost' has the meaning given such term in section 
1847A(c)(6)(B) of the Social Security Act.''; and
          (2) in section 2723 (42 U.S.C. 300gg-22)--
                  (A) in subsection (a)--
                          (i) in paragraph (1), by inserting 
                        ``(other than subsections (a) and (b) 
                        of section 2799A-11)'' after ``part 
                        D''; and
                          (ii) in paragraph (2), by inserting 
                        ``(other than subsections (a) and (b) 
                        of section 2799A-11)'' after ``part 
                        D''; and
                  (B) in subsection (b)--
                          (i) in paragraph (1), by inserting 
                        ``(other than subsections (a) and (b) 
                        of section 2799A-11)'' after ``part 
                        D'';
                          (ii) in paragraph (2)(A), by 
                        inserting ``(other than subsections (a) 
                        and (b) of section 2799A-11)'' after 
                        ``part D''; and
                          (iii) in paragraph (2)(C)(ii), by 
                        inserting ``(other than subsections (a) 
                        and (b) of section 2799A-11)'' after 
                        ``part D''.
  (b) ERISA.--
          (1) In general.--Subtitle B of title I of the 
        Employee Retirement Income Security Act of 1974 (29 
        U.S.C. 1021 et seq.) is amended--
                  (A) in subpart B of part 7 (29 U.S.C. 1185 et 
                seq.), by adding at the end the following:

``SEC. 726. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

  ``(a) In General.--For plan years beginning on or after 
January 1, 2024, a group health plan (or health insurance 
issuer offering group health insurance coverage in connection 
with such a plan) or an entity or subsidiary providing pharmacy 
benefits management services on behalf of such a plan or issuer 
shall not enter into a contract with a drug manufacturer, 
distributor, wholesaler, subcontractor, rebate aggregator, or 
any associated third party that limits the disclosure of 
information to plan sponsors in such a manner that prevents the 
plan or issuer, or an entity or subsidiary providing pharmacy 
benefits management services on behalf of a plan or issuer, 
from making the reports described in subsection (b).
  ``(b) Reports.--
          ``(1) In general.--For plan years beginning on or 
        after January 1, 2024, not less frequently than once 
        every 6 months, a health insurance issuer offering 
        group health insurance coverage or an entity providing 
        pharmacy benefits management services on behalf of a 
        group health plan or an issuer providing group health 
        insurance coverage shall submit to the plan sponsor (as 
        defined in section 3(16)(B)) of such group health plan 
        or group health insurance coverage a report in 
        accordance with this subsection and make such report 
        available to the plan sponsor in a machine-readable 
        format. Each such report shall include, with respect to 
        the applicable group health plan or health insurance 
        coverage--
                  ``(A) as applicable, information collected 
                from drug manufacturers by such issuer or 
                entity on the total amount of copayment 
                assistance dollars paid, or copayment cards 
                applied, that were funded by the drug 
                manufacturer with respect to the participants 
                and beneficiaries in such plan or coverage;
                  ``(B) a list of each drug covered by such 
                plan, issuer, or entity providing pharmacy 
                benefit management services that was dispensed 
                during the reporting period, including, with 
                respect to each such drug during the reporting 
                period--
                          ``(i) the brand name, chemical 
                        entity, and National Drug Code;
                          ``(ii) the number of participants and 
                        beneficiaries for whom the drug was 
                        filled during the plan year, the total 
                        number of prescription fills for the 
                        drug (including original prescriptions 
                        and refills), and the total number of 
                        dosage units of the drug dispensed 
                        across the plan year, including whether 
                        the dispensing channel was by retail, 
                        mail order, or specialty pharmacy;
                          ``(iii) the wholesale acquisition 
                        cost, listed as cost per days supply 
                        and cost per pill, or in the case of a 
                        drug in another form, per dose;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries on such drug, including 
                        participant and beneficiary spending 
                        through copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for any drug for which gross 
                        spending of the group health plan or 
                        health insurance coverage exceeded 
                        $10,000 during the reporting period--
                                  ``(I) a list of all other 
                                drugs in the same therapeutic 
                                category or class, including 
                                brand name drugs and biological 
                                products and generic drugs or 
                                biosimilar biological products 
                                that are in the same 
                                therapeutic category or class 
                                as such drug; and
                                  ``(II) the rationale for 
                                preferred formulary placement 
                                of such drug in that 
                                therapeutic category or class, 
                                if applicable;
                  ``(C) a list of each therapeutic category or 
                class of drugs that were dispensed under the 
                health plan or health insurance coverage during 
                the reporting period, and, with respect to each 
                such therapeutic category or class of drugs, 
                during the reporting period--
                          ``(i) total gross spending by the 
                        plan, before manufacturer rebates, 
                        fees, or other manufacturer 
                        remuneration;
                          ``(ii) the number of participants and 
                        beneficiaries who filled a prescription 
                        for a drug in that category or class;
                          ``(iii) if applicable to that 
                        category or class, a description of the 
                        formulary tiers and utilization 
                        mechanisms (such as prior authorization 
                        or step therapy) employed for drugs in 
                        that category or class;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries, including participant 
                        and beneficiary spending through 
                        copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for each therapeutic category 
                        or class under which 3 or more drugs 
                        are included on the formulary of such 
                        plan or coverage--
                                  ``(I) the amount received, or 
                                expected to be received, from 
                                drug manufacturers in rebates, 
                                fees, alternative discounts, or 
                                other remuneration--
                                          ``(aa) that has been 
                                        paid, or is to be paid, 
                                        by drug manufacturers 
                                        for claims incurred 
                                        during the reporting 
                                        period; or
                                          ``(bb) that is 
                                        related to utilization 
                                        of drugs, in such 
                                        therapeutic category or 
                                        class;
                                  ``(II) the total net 
                                spending, after deducting 
                                rebates, price concessions, 
                                alternative discounts or other 
                                remuneration from drug 
                                manufacturers, by the health 
                                plan or health insurance 
                                coverage on that category or 
                                class of drugs; and
                                  ``(III) the net price per 
                                course of treatment or single 
                                fill, such as a 30-day supply 
                                or 90-day supply, incurred by 
                                the health plan or health 
                                insurance coverage and its 
                                participants and beneficiaries, 
                                after manufacturer rebates, 
                                fees, and other remuneration 
                                for drugs dispensed within such 
                                therapeutic category or class 
                                during the reporting period;
                  ``(D) total gross spending on prescription 
                drugs by the plan or coverage during the 
                reporting period, before rebates and other 
                manufacturer fees or remuneration;
                  ``(E) total amount received, or expected to 
                be received, by the health plan or health 
                insurance coverage in drug manufacturer 
                rebates, fees, alternative discounts, and all 
                other remuneration received from the 
                manufacturer or any third party, other than the 
                plan sponsor, related to utilization of drug or 
                drug spending under that health plan or health 
                insurance coverage during the reporting period;
                  ``(F) the total net spending on prescription 
                drugs by the health plan or health insurance 
                coverage during the reporting period; and
                  ``(G) amounts paid directly or indirectly in 
                rebates, fees, or any other type of 
                remuneration to brokers, consultants, advisors, 
                or any other individual or firm who referred 
                the group health plan's or health insurance 
                issuer's business to the pharmacy benefit 
                manager.
          ``(2) Privacy requirements.--Health insurance issuers 
        offering group health insurance coverage and entities 
        providing pharmacy benefits management services on 
        behalf of a group health plan shall provide information 
        under paragraph (1) in a manner consistent with the 
        privacy, security, and breach notification regulations 
        promulgated under section 264(c) of the Health 
        Insurance Portability and Accountability Act of 1996, 
        and shall restrict the use and disclosure of such 
        information according to such privacy regulations.
          ``(3) Disclosure and redisclosure.--
                  ``(A) Limitation to business associates.--A 
                group health plan receiving a report under 
                paragraph (1) may disclose such information 
                only to business associates of such plan as 
                defined in section 160.103 of title 45, Code of 
                Federal Regulations (or successor regulations).
                  ``(B) Clarification regarding public 
                disclosure of information.--Nothing in this 
                section prevents a health insurance issuer 
                offering group health insurance coverage or an 
                entity providing pharmacy benefits management 
                services on behalf of a group health plan from 
                placing reasonable restrictions on the public 
                disclosure of the information contained in a 
                report described in paragraph (1), except that 
                such issuer or entity may not restrict 
                disclosure of such report to the Department of 
                Health and Human Services, the Department of 
                Labor, the Department of the Treasury, or 
                applicable State agencies.
                  ``(C) Limited form of report.--The Secretary 
                shall define through rulemaking a limited form 
                of the report under paragraph (1) required of 
                plan sponsors who are drug manufacturers, drug 
                wholesalers, or other direct participants in 
                the drug supply chain, in order to prevent 
                anti-competitive behavior.
          ``(4) Report to gao.--A health insurance issuer 
        offering group health insurance coverage or an entity 
        providing pharmacy benefits management services on 
        behalf of a group health plan shall submit to the 
        Comptroller General of the United States each of the 
        first 4 reports submitted to a plan sponsor under 
        paragraph (1) with respect to such coverage or plan, 
        and other such reports as requested, in accordance with 
        the privacy requirements under paragraph (2), the 
        disclosure and redisclosure standards under paragraph 
        (3), the standards specified pursuant to paragraph (5), 
        and such other information that the Comptroller General 
        determines necessary to carry out the study under 
        section 602(d) of the Restoring Hope for Mental Health 
        and Well-Being Act of 2022.
          ``(5) Standard format.--Not later than June 1, 2023, 
        the Secretary shall specify through rulemaking 
        standards for health insurance issuers and entities 
        required to submit reports under paragraph (4) to 
        submit such reports in a standard format.
  ``(c) Enforcement.--
          ``(1) In general.--The Secretary, in consultation 
        with the Secretary of Health and Human Services and the 
        Secretary of the Treasury, shall enforce this section.
          ``(2) Failure to provide timely information.--A 
        health insurance issuer or an entity providing pharmacy 
        benefit management services that violates subsection 
        (a) or fails to provide information required under 
        subsection (b), or a drug manufacturer that fails to 
        provide information under subsection (b)(1)(A) in a 
        timely manner, shall be subject to a civil monetary 
        penalty in the amount of $10,000 for each day during 
        which such violation continues or such information is 
        not disclosed or reported.
          ``(3) False information.--A health insurance issuer, 
        entity providing pharmacy benefit management services, 
        or drug manufacturer that knowingly provides false 
        information under this section shall be subject to a 
        civil money penalty in an amount not to exceed $100,000 
        for each item of false information. Such civil money 
        penalty shall be in addition to other penalties as may 
        be prescribed by law.
          ``(4) Procedure.--The provisions of section 1128A of 
        the Social Security Act, other than subsection (a) and 
        (b) and the first sentence of subsection (c)(1) of such 
        section shall apply to civil monetary penalties under 
        this subsection in the same manner as such provisions 
        apply to a penalty or proceeding under section 1128A of 
        the Social Security Act.
          ``(5) Waivers.--The Secretary may waive penalties 
        under paragraph (2), or extend the period of time for 
        compliance with a requirement of this section, for an 
        entity in violation of this section that has made a 
        good-faith effort to comply with this section.
  ``(d) Rule of Construction.--Nothing in this section shall be 
construed to permit a health insurance issuer, group health 
plan, or other entity to restrict disclosure to, or otherwise 
limit the access of, the Department of Labor to a report 
described in subsection (b)(1) or information related to 
compliance with subsection (a) by such issuer, plan, or entity.
  ``(e) Definition.--In this section, the term `wholesale 
acquisition cost' has the meaning given such term in section 
1847A(c)(6)(B) of the Social Security Act.''; and
                  (B) in section 502(b)(3) (29 U.S.C. 
                1132(b)(3)), by inserting ``(other than section 
                726)'' after ``part 7''.
          (2) Clerical amendment.--The table of contents in 
        section 1 of the Employee Retirement Income Security 
        Act of 1974 (29 U.S.C. 1001 et seq.) is amended by 
        inserting after the item relating to section 725 the 
        following new item:

``Sec. 726. Oversight of pharmacy benefit manager services.''.

  (c) IRC.--
          (1) In general.--Subchapter B of chapter 100 of the 
        Internal Revenue Code of 1986 is amended by adding at 
        the end the following:

``SEC. 9826. OVERSIGHT OF PHARMACY BENEFIT MANAGER SERVICES.

  ``(a) In General.--For plan years beginning on or after 
January 1, 2024, a group health plan or an entity or subsidiary 
providing pharmacy benefits management services on behalf of 
such a plan shall not enter into a contract with a drug 
manufacturer, distributor, wholesaler, subcontractor, rebate 
aggregator, or any associated third party that limits the 
disclosure of information to plan sponsors in such a manner 
that prevents the plan, or an entity or subsidiary providing 
pharmacy benefits management services on behalf of a plan, from 
making the reports described in subsection (b).
  ``(b) Reports.--
          ``(1) In general.--For plan years beginning on or 
        after January 1, 2024, not less frequently than once 
        every 6 months, an entity providing pharmacy benefits 
        management services on behalf of a group health plan 
        shall submit to the plan sponsor (as defined in section 
        3(16)(B) of the Employee Retirement Income Security Act 
        of 1974) of such group health plan a report in 
        accordance with this subsection and make such report 
        available to the plan sponsor in a machine-readable 
        format. Each such report shall include, with respect to 
        the applicable group health plan--
                  ``(A) as applicable, information collected 
                from drug manufacturers by such entity on the 
                total amount of copayment assistance dollars 
                paid, or copayment cards applied, that were 
                funded by the drug manufacturer with respect to 
                the participants and beneficiaries in such 
                plan;
                  ``(B) a list of each drug covered by such 
                plan or entity providing pharmacy benefit 
                management services that was dispensed during 
                the reporting period, including, with respect 
                to each such drug during the reporting period--
                          ``(i) the brand name, chemical 
                        entity, and National Drug Code;
                          ``(ii) the number of participants and 
                        beneficiaries for whom the drug was 
                        filled during the plan year, the total 
                        number of prescription fills for the 
                        drug (including original prescriptions 
                        and refills), and the total number of 
                        dosage units of the drug dispensed 
                        across the plan year, including whether 
                        the dispensing channel was by retail, 
                        mail order, or specialty pharmacy;
                          ``(iii) the wholesale acquisition 
                        cost, listed as cost per days supply 
                        and cost per pill, or in the case of a 
                        drug in another form, per dose;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries on such drug, including 
                        participant and beneficiary spending 
                        through copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for any drug for which gross 
                        spending of the group health plan 
                        exceeded $10,000 during the reporting 
                        period--
                                  ``(I) a list of all other 
                                drugs in the same therapeutic 
                                category or class, including 
                                brand name drugs and biological 
                                products and generic drugs or 
                                biosimilar biological products 
                                that are in the same 
                                therapeutic category or class 
                                as such drug; and
                                  ``(II) the rationale for 
                                preferred formulary placement 
                                of such drug in that 
                                therapeutic category or class, 
                                if applicable;
                  ``(C) a list of each therapeutic category or 
                class of drugs that were dispensed under the 
                health plan during the reporting period, and, 
                with respect to each such therapeutic category 
                or class of drugs, during the reporting 
                period--
                          ``(i) total gross spending by the 
                        plan, before manufacturer rebates, 
                        fees, or other manufacturer 
                        remuneration;
                          ``(ii) the number of participants and 
                        beneficiaries who filled a prescription 
                        for a drug in that category or class;
                          ``(iii) if applicable to that 
                        category or class, a description of the 
                        formulary tiers and utilization 
                        mechanisms (such as prior authorization 
                        or step therapy) employed for drugs in 
                        that category or class;
                          ``(iv) the total out-of-pocket 
                        spending by participants and 
                        beneficiaries, including participant 
                        and beneficiary spending through 
                        copayments, coinsurance, and 
                        deductibles; and
                          ``(v) for each therapeutic category 
                        or class under which 3 or more drugs 
                        are included on the formulary of such 
                        plan--
                                  ``(I) the amount received, or 
                                expected to be received, from 
                                drug manufacturers in rebates, 
                                fees, alternative discounts, or 
                                other remuneration--
                                          ``(aa) that has been 
                                        paid, or is to be paid, 
                                        by drug manufacturers 
                                        for claims incurred 
                                        during the reporting 
                                        period; or
                                          ``(bb) that is 
                                        related to utilization 
                                        of drugs, in such 
                                        therapeutic category or 
                                        class;
                                  ``(II) the total net 
                                spending, after deducting 
                                rebates, price concessions, 
                                alternative discounts or other 
                                remuneration from drug 
                                manufacturers, by the health 
                                plan on that category or class 
                                of drugs; and
                                  ``(III) the net price per 
                                course of treatment or single 
                                fill, such as a 30-day supply 
                                or 90-day supply, incurred by 
                                the health plan and its 
                                participants and beneficiaries, 
                                after manufacturer rebates, 
                                fees, and other remuneration 
                                for drugs dispensed within such 
                                therapeutic category or class 
                                during the reporting period;
                  ``(D) total gross spending on prescription 
                drugs by the plan during the reporting period, 
                before rebates and other manufacturer fees or 
                remuneration;
                  ``(E) total amount received, or expected to 
                be received, by the health plan in drug 
                manufacturer rebates, fees, alternative 
                discounts, and all other remuneration received 
                from the manufacturer or any third party, other 
                than the plan sponsor, related to utilization 
                of drug or drug spending under that health plan 
                during the reporting period;
                  ``(F) the total net spending on prescription 
                drugs by the health plan during the reporting 
                period; and
                  ``(G) amounts paid directly or indirectly in 
                rebates, fees, or any other type of 
                remuneration to brokers, consultants, advisors, 
                or any other individual or firm who referred 
                the group health plan's business to the 
                pharmacy benefit manager.
          ``(2) Privacy requirements.--Entities providing 
        pharmacy benefits management services on behalf of a 
        group health plan shall provide information under 
        paragraph (1) in a manner consistent with the privacy, 
        security, and breach notification regulations 
        promulgated under section 264(c) of the Health 
        Insurance Portability and Accountability Act of 1996, 
        and shall restrict the use and disclosure of such 
        information according to such privacy regulations.
          ``(3) Disclosure and redisclosure.--
                  ``(A) Limitation to business associates.--A 
                group health plan receiving a report under 
                paragraph (1) may disclose such information 
                only to business associates of such plan as 
                defined in section 160.103 of title 45, Code of 
                Federal Regulations (or successor regulations).
                  ``(B) Clarification regarding public 
                disclosure of information.--Nothing in this 
                section prevents an entity providing pharmacy 
                benefits management services on behalf of a 
                group health plan from placing reasonable 
                restrictions on the public disclosure of the 
                information contained in a report described in 
                paragraph (1), except that such entity may not 
                restrict disclosure of such report to the 
                Department of Health and Human Services, the 
                Department of Labor, the Department of the 
                Treasury, or applicable State agencies.
                  ``(C) Limited form of report.--The Secretary 
                shall define through rulemaking a limited form 
                of the report under paragraph (1) required of 
                plan sponsors who are drug manufacturers, drug 
                wholesalers, or other direct participants in 
                the drug supply chain, in order to prevent 
                anti-competitive behavior.
          ``(4) Report to gao.--An entity providing pharmacy 
        benefits management services on behalf of a group 
        health plan shall submit to the Comptroller General of 
        the United States each of the first 4 reports submitted 
        to a plan sponsor under paragraph (1) with respect to 
        such plan, and other such reports as requested, in 
        accordance with the privacy requirements under 
        paragraph (2), the disclosure and redisclosure 
        standards under paragraph (3), the standards specified 
        pursuant to paragraph (5), and such other information 
        that the Comptroller General determines necessary to 
        carry out the study under section 602(d) of the 
        Restoring Hope for Mental Health and Well-Being Act of 
        2022.
          ``(5) Standard format.--Not later than June 1, 2023, 
        the Secretary shall specify through rulemaking 
        standards for entities required to submit reports under 
        paragraph (4) to submit such reports in a standard 
        format.
  ``(c) Enforcement.--
          ``(1) In general.--The Secretary, in consultation 
        with the Secretary of Labor and the Secretary of Health 
        and Human Services, shall enforce this section.
          ``(2) Failure to provide timely information.--An 
        entity providing pharmacy benefit management services 
        that violates subsection (a) or fails to provide 
        information required under subsection (b), or a drug 
        manufacturer that fails to provide information under 
        subsection (b)(1)(A) in a timely manner, shall be 
        subject to a civil monetary penalty in the amount of 
        $10,000 for each day during which such violation 
        continues or such information is not disclosed or 
        reported.
          ``(3) False information.--An entity providing 
        pharmacy benefit management services, or drug 
        manufacturer that knowingly provides false information 
        under this section shall be subject to a civil money 
        penalty in an amount not to exceed $100,000 for each 
        item of false information. Such civil money penalty 
        shall be in addition to other penalties as may be 
        prescribed by law.
          ``(4) Procedure.--The provisions of section 1128A of 
        the Social Security Act, other than subsection (a) and 
        (b) and the first sentence of subsection (c)(1) of such 
        section shall apply to civil monetary penalties under 
        this subsection in the same manner as such provisions 
        apply to a penalty or proceeding under section 1128A of 
        the Social Security Act.
          ``(5) Waivers.--The Secretary may waive penalties 
        under paragraph (2), or extend the period of time for 
        compliance with a requirement of this section, for an 
        entity in violation of this section that has made a 
        good-faith effort to comply with this section.
  ``(d) Rule of Construction.--Nothing in this section shall be 
construed to permit a group health plan or other entity to 
restrict disclosure to, or otherwise limit the access of, the 
Department of the Treasury to a report described in subsection 
(b)(1) or information related to compliance with subsection (a) 
by such plan or entity.
  ``(e) Definition.--In this section, the term `wholesale 
acquisition cost' has the meaning given such term in section 
1847A(c)(6)(B) of the Social Security Act.''.
          (2) Clerical amendment.--The table of sections for 
        subchapter B of chapter 100 of the Internal Revenue 
        Code of 1986 is amended by adding at the end the 
        following new item:

``Sec. 9826. Oversight of pharmacy benefit manager services.''.

  (d) GAO Study.--
          (1) In general.--Not later than 3 years after the 
        date of enactment of this Act, the Comptroller General 
        of the United States shall submit to Congress a report 
        on--
                  (A) pharmacy networks of group health plans, 
                health insurance issuers, and entities 
                providing pharmacy benefit management services 
                under such group health plan or group or 
                individual health insurance coverage, including 
                networks that have pharmacies that are under 
                common ownership (in whole or part) with group 
                health plans, health insurance issuers, or 
                entities providing pharmacy benefit management 
                services or pharmacy benefit administrative 
                services under group health plan or group or 
                individual health insurance coverage;
                  (B) as it relates to pharmacy networks that 
                include pharmacies under common ownership 
                described in subparagraph (A)--
                          (i) whether such networks are 
                        designed to encourage enrollees of a 
                        plan or coverage to use such pharmacies 
                        over other network pharmacies for 
                        specific services or drugs, and if so, 
                        the reasons the networks give for 
                        encouraging use of such pharmacies; and
                          (ii) whether such pharmacies are used 
                        by enrollees disproportionately more in 
                        the aggregate or for specific services 
                        or drugs compared to other network 
                        pharmacies;
                  (C) whether group health plans and health 
                insurance issuers offering group or individual 
                health insurance coverage have options to elect 
                different network pricing arrangements in the 
                marketplace with entities that provide pharmacy 
                benefit management services, the prevalence of 
                electing such different network pricing 
                arrangements;
                  (D) pharmacy network design parameters that 
                encourage enrollees in the plan or coverage to 
                fill prescriptions at mail order, specialty, or 
                retail pharmacies that are wholly or partially-
                owned by that issuer or entity; and
                  (E) the degree to which mail order, 
                specialty, or retail pharmacies that dispense 
                prescription drugs to an enrollee in a group 
                health plan or health insurance coverage that 
                are under common ownership (in whole or part) 
                with group health plans, health insurance 
                issuers, or entities providing pharmacy benefit 
                management services or pharmacy benefit 
                administrative services under group health plan 
                or group or individual health insurance 
                coverage receive reimbursement that is greater 
                than the median price charged to the group 
                health plan or health insurance issuer when the 
                same drug is dispensed to enrollees in the plan 
                or coverage by other pharmacies included in the 
                pharmacy network of that plan, issuer, or 
                entity that are not wholly or partially owned 
                by the health insurance issuer or entity 
                providing pharmacy benefit management services.
          (2) Requirement.--The Comptroller General of the 
        United States shall ensure that the report under 
        paragraph (1) does not contain information that would 
        allow a reader to identify a specific plan or entity 
        providing pharmacy benefits management services or 
        otherwise contain commercial or financial information 
        that is privileged or confidential.
          (3) Definitions.--In this subsection, the terms 
        ``group health plan'', ``health insurance coverage'', 
        and ``health insurance issuer'' have the meanings given 
        such terms in section 2791 of the Public Health Service 
        Act (42 U.S.C. 300gg-91).

SEC. 603. MEDICARE IMPROVEMENT FUND.

  Section 1898(b)(1) of the Social Security Act (42 U.S.C. 
1395iii(b)(1)) is amended by striking ``$5,000,000'' and 
inserting ``$1,029,000,000''.

SEC. 604. LIMITATIONS ON AUTHORITY.

  In carrying out any program of the Substance Abuse and Mental 
Health Services Administration whose statutory authorization is 
enacted or amended by this Act, the Secretary of Health and 
Human Services shall not allocate funding, or require award 
recipients to prioritize, dedicate, or allocate funding, 
without consideration of the incidence, prevalence, or 
determinants of mental health or substance use issues, unless 
such allocation or requirement is consistent with statute, 
regulation, or other Federal law.

         PART E--TEXT OF AMENDMENTS TO H.R. 7666 MADE IN ORDER

 1. An Amendment To Be Offered by Representative Bera of California or 
                 His Designee, Debatable for 10 Minutes

  After section 331, insert the following new subtitle:

   Subtitle E--Improving Emergency Department Mental Health Access, 
                        Services, and Responders

SEC. 341. HELPING EMERGENCY RESPONDERS OVERCOME.

  (a) Data System to Capture National Public Safety Officer 
Suicide Incidence.--The Public Health Service Act is amended by 
inserting before section 318 of such Act (42 U.S.C. 247c) the 
following:

``SEC. 317V. DATA SYSTEM TO CAPTURE NATIONAL PUBLIC SAFETY OFFICER 
                    SUICIDE INCIDENCE.

  ``(a) In General.--The Secretary, in coordination with the 
Director of the Centers for Disease Control and Prevention and 
other agencies as the Secretary determines appropriate, may--
          ``(1) develop and maintain a data system, to be known 
        as the Public Safety Officer Suicide Reporting System, 
        for the purposes of--
                  ``(A) collecting data on the suicide 
                incidence among public safety officers; and
                  ``(B) facilitating the study of successful 
                interventions to reduce suicide among public 
                safety officers; and
          ``(2) integrate such system into the National Violent 
        Death Reporting System, so long as the Secretary 
        determines such integration to be consistent with the 
        purposes described in paragraph (1).
  ``(b) Data Collection.--In collecting data for the Public 
Safety Officer Suicide Reporting System, the Secretary shall, 
at a minimum, collect the following information:
          ``(1) The total number of suicides in the United 
        States among all public safety officers in a given 
        calendar year.
          ``(2) Suicide rates for public safety officers in a 
        given calendar year, disaggregated by--
                  ``(A) age and gender of the public safety 
                officer;
                  ``(B) State;
                  ``(C) occupation; including both the 
                individual's role in their public safety agency 
                and their primary occupation in the case of 
                volunteer public safety officers;
                  ``(D) where available, the status of the 
                public safety officer as volunteer, paid-on-
                call, or career; and
                  ``(E) status of the public safety officer as 
                active or retired.
  ``(c) Consultation During Development.--In developing the 
Public Safety Officer Suicide Reporting System, the Secretary 
shall consult with non-Federal experts to determine the best 
means to collect data regarding suicide incidence in a safe, 
sensitive, anonymous, and effective manner. Such non-Federal 
experts shall include, as appropriate, the following:
          ``(1) Public health experts with experience in 
        developing and maintaining suicide registries.
          ``(2) Organizations that track suicide among public 
        safety officers.
          ``(3) Mental health experts with experience in 
        studying suicide and other profession-related traumatic 
        stress.
          ``(4) Clinicians with experience in diagnosing and 
        treating mental health issues.
          ``(5) Active and retired volunteer, paid-on-call, and 
        career public safety officers.
          ``(6) Relevant national police, and fire and 
        emergency medical services, organizations.
  ``(d) Data Privacy and Security.--In developing and 
maintaining the Public Safety Officer Suicide Reporting System, 
the Secretary shall ensure that all applicable Federal privacy 
and security protections are followed to ensure that--
          ``(1) the confidentiality and anonymity of suicide 
        victims and their families are protected, including so 
        as to ensure that data cannot be used to deny benefits; 
        and
          ``(2) data is sufficiently secure to prevent 
        unauthorized access.
  ``(e) Reporting.--
          ``(1) Annual report.--Not later than 2 years after 
        the date of enactment of the Restoring Hope for Mental 
        Health and Well-Being Act of 2022, and biannually 
        thereafter, the Secretary shall submit a report to the 
        Congress on the suicide incidence among public safety 
        officers. Each such report shall--
                  ``(A) include the number and rate of such 
                suicide incidence, disaggregated by age, 
                gender, and State of employment;
                  ``(B) identify characteristics and 
                contributing circumstances for suicide among 
                public safety officers;
                  ``(C) disaggregate rates of suicide by--
                          ``(i) occupation;
                          ``(ii) status as volunteer, paid-on-
                        call, or career; and
                          ``(iii) status as active or retired;
                  ``(D) include recommendations for further 
                study regarding the suicide incidence among 
                public safety officers;
                  ``(E) specify in detail, if found, any 
                obstacles in collecting suicide rates for 
                volunteers and include recommended improvements 
                to overcome such obstacles;
                  ``(F) identify options for interventions to 
                reduce suicide among public safety officers; 
                and
                  ``(G) describe procedures to ensure the 
                confidentiality and anonymity of suicide 
                victims and their families, as described in 
                subsection (d)(1).
          ``(2) Public availability.--Upon the submission of 
        each report to the Congress under paragraph (1), the 
        Secretary shall make the full report publicly available 
        on the website of the Centers for Disease Control and 
        Prevention.
  ``(f) Definition.--In this section, the term `public safety 
officer' means--
          ``(1) a public safety officer as defined in section 
        1204 of the Omnibus Crime Control and Safe Streets Act 
        of 1968; or
          ``(2) a public safety telecommunicator as described 
        in detailed occupation 43-5031 in the Standard 
        Occupational Classification Manual of the Office of 
        Management and Budget (2018).
  ``(g) Prohibited Use of Information.--Notwithstanding any 
other provision of law, if an individual is identified as 
deceased based on information contained in the Public Safety 
Officer Suicide Reporting System, such information may not be 
used to deny or rescind life insurance payments or other 
benefits to a survivor of the deceased individual.''.
  (b) Peer-support Behavioral Health and Wellness Programs 
Within Fire Departments and Emergency Medical Service 
Agencies.--
          (1) In general.--Part B of title III of the Public 
        Health Service Act (42 U.S.C. 243 et seq.) is amended 
        by adding at the end the following:

``SEC. 320C. PEER-SUPPORT BEHAVIORAL HEALTH AND WELLNESS PROGRAMS 
                    WITHIN FIRE DEPARTMENTS AND EMERGENCY MEDICAL 
                    SERVICE AGENCIES.

  ``(a) In General.--The Secretary may award grants to eligible 
entities for the purpose of establishing or enhancing peer-
support behavioral health and wellness programs within fire 
departments and emergency medical services agencies.
  ``(b) Program Description.--A peer-support behavioral health 
and wellness program funded under this section shall--
          ``(1) use career and volunteer members of fire 
        departments or emergency medical services agencies to 
        serve as peer counselors;
          ``(2) provide training to members of career, 
        volunteer, and combination fire departments or 
        emergency medical service agencies to serve as such 
        peer counselors;
          ``(3) purchase materials to be used exclusively to 
        provide such training; and
          ``(4) disseminate such information and materials as 
        are necessary to conduct the program.
  ``(c) Definition.--In this section:
          ``(1) The term `eligible entity' means a nonprofit 
        organization with expertise and experience with respect 
        to the health and life safety of members of fire and 
        emergency medical services agencies.
          ``(2) The term `member'--
                  ``(A) with respect to an emergency medical 
                services agency, means an employee, regardless 
                of rank or whether the employee receives 
                compensation (as defined in section 1204(7) of 
                the Omnibus Crime Control and Safe Streets Act 
                of 1968); and
                  ``(B) with respect to a fire department, 
                means any employee, regardless of rank or 
                whether the employee receives compensation, of 
                a Federal, State, Tribal, or local fire 
                department who is responsible for responding to 
                calls for emergency service.''.
          (2) Technical correction.--Effective as if included 
        in the enactment of the Children's Health Act of 2000 
        (Public Law 106-310), the amendment instruction in 
        section 1603 of such Act is amended by striking ``Part 
        B of the Public Health Service Act'' and inserting 
        ``Part B of title III of the Public Health Service 
        Act''.
  (c) Health Care Provider Behavioral Health and Wellness 
Programs.--Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.), as amended by subsection (b)(1), is 
further amended by adding at the end the following:

``SEC. 320D. HEALTH CARE PROVIDER BEHAVIORAL HEALTH AND WELLNESS 
                    PROGRAMS.

  ``(a) In General.--The Secretary may award grants to eligible 
entities for the purpose of establishing or enhancing 
behavioral health and wellness programs for health care 
providers.
  ``(b) Program Description.--A behavioral health and wellness 
program funded under this section shall--
          ``(1) provide confidential support services for 
        health care providers to help handle stressful or 
        traumatic patient-related events, including counseling 
        services and wellness seminars;
          ``(2) provide training to health care providers to 
        serve as peer counselors to other health care 
        providers;
          ``(3) purchase materials to be used exclusively to 
        provide such training; and
          ``(4) disseminate such information and materials as 
        are necessary to conduct such training and provide such 
        peer counseling.
  ``(c) Definitions.--In this section, the term `eligible 
entity' means a hospital, including a critical access hospital 
(as defined in section 1861(mm)(1) of the Social Security Act) 
or a disproportionate share hospital (as defined under section 
1923(a)(1)(A) of such Act), a Federally-qualified health center 
(as defined in section 1905(1)(2)(B) of such Act), or any other 
health care facility.''.
  (d) Development of Resources for Educating Mental Health 
Professionals About Treating Fire Fighters and Emergency 
Medical Services Personnel.--
          (1) In general.--The Secretary of Health and Human 
        Services shall develop and make publicly available 
        resources that may be used by the Federal Government 
        and other entities to educate mental health 
        professionals about--
                  (A) the culture of Federal, State, Tribal, 
                and local career, volunteer, and combination 
                fire departments and emergency medical services 
                agencies;
                  (B) the different stressors experienced by 
                firefighters and emergency medical services 
                personnel, supervisory firefighters and 
                emergency medical services personnel, and chief 
                officers of fire departments and emergency 
                medical services agencies;
                  (C) challenges encountered by retired 
                firefighters and emergency medical services 
                personnel; and
                  (D) evidence-based therapies for mental 
                health issues common to firefighters and 
                emergency medical services personnel within 
                such departments and agencies.
          (2) Consultation.--In developing resources under 
        paragraph (1), the Secretary of Health and Human 
        Services shall consult with national fire and emergency 
        medical services organizations.
          (3) Definitions.--In this subsection:
                  (A) The term ``firefighter'' means any 
                employee, regardless of rank or whether the 
                employee receives compensation, of a Federal, 
                State, Tribal, or local fire department who is 
                responsible for responding to calls for 
                emergency service.
                  (B) The term ``emergency medical services 
                personnel'' means any employee, regardless of 
                rank or whether the employee receives 
                compensation, as defined in section 1204(7) of 
                the Omnibus Crime Control and Safe Streets Act 
                of 1968 (34 U.S.C. 10284(7)).
                  (C) The term ``chief officer'' means any 
                individual who is responsible for the overall 
                operation of a fire department or an emergency 
                medical services agency, irrespective of 
                whether such individual also serves as a 
                firefighter or emergency medical services 
                personnel.
  (e) Best Practices and Other Resources for Addressing 
Posttraumatic Stress Disorder in Public Safety Officers.--
          (1) Development; updates.--The Secretary of Health 
        and Human Services shall--
                  (A) develop and assemble evidence-based best 
                practices and other resources to identify, 
                prevent, and treat posttraumatic stress 
                disorder and co-occurring disorders in public 
                safety officers; and
                  (B) reassess and update, as the Secretary 
                determines necessary, such best practices and 
                resources, including based upon the options for 
                interventions to reduce suicide among public 
                safety officers identified in the annual 
                reports required by section 317V(e)(1)(F) of 
                the Public Health Service Act, as added by 
                subsection (a).
          (2) Consultation.--In developing, assembling, and 
        updating the best practices and resources under 
        paragraph (1), the Secretary of Health and Human 
        Services shall consult with, at a minimum, the 
        following:
                  (A) Public health experts.
                  (B) Mental health experts with experience in 
                studying suicide and other profession-related 
                traumatic stress.
                  (C) Clinicians with experience in diagnosing 
                and treating mental health issues.
                  (D) Relevant national police, fire, and 
                emergency medical services organizations.
          (3) Availability.--The Secretary of Health and Human 
        Services shall make the best practices and resources 
        under paragraph (1) available to Federal, State, and 
        local fire, law enforcement, and emergency medical 
        services agencies.
          (4) Federal training and development programs.--The 
        Secretary of Health and Human Services shall work with 
        Federal departments and agencies, including the United 
        States Fire Administration, to incorporate education 
        and training on the best practices and resources under 
        paragraph (1) into Federal training and development 
        programs for public safety officers.
          (5) Definition.--In this subsection, the term 
        ``public safety officer'' means--
                  (A) a public safety officer as defined in 
                section 1204 of the Omnibus Crime Control and 
                Safe Streets Act of 1968 (34 U.S.C. 10284); or
                  (B) a public safety telecommunicator as 
                described in detailed occupation 43-5031 in the 
                Standard Occupational Classification Manual of 
                the Office of Management and Budget (2018).
                              ----------                              


 2. An Amendment To Be Offered by Representative Davis of Illinois or 
                 His Designee, Debatable for 10 Minutes

  At the end of title II, add the following new subtitle:

                  Subtitle G--Opioid Epidemic Response

SEC. 271. OPIOID PRESCRIPTION VERIFICATION.

  (a) Materials for Training Pharmacists on Certain 
Circumstances Under Which a Pharmacist May Decline to Fill a 
Prescription.--
          (1) Updates to materials.--Section 3212(a) of the 
        SUPPORT for Patients and Communities Act (21 U.S.C. 829 
        note) is amended by striking ``Not later than 1 year 
        after the date of enactment of this Act, the Secretary 
        of Health and Human Services, in consultation with the 
        Administrator of the Drug Enforcement Administration, 
        Commissioner of Food and Drugs, Director of the Centers 
        for Disease Control and Prevention, and Assistant 
        Secretary for Mental Health and Substance Use, shall 
        develop and disseminate'' and inserting ``The Secretary 
        of Health and Human Services, in consultation with the 
        Administrator of the Drug Enforcement Administration, 
        Commissioner of Food and Drugs, Director of the Centers 
        for Disease Control and Prevention, and Assistant 
        Secretary for Mental Health and Substance Use, shall 
        develop and disseminate not later than 1 year after the 
        date of enactment of this Act, and update periodically 
        thereafter''.
          (2) Materials included.--Section 3212(b) of the 
        SUPPORT for Patients and Communities Act (21 U.S.C. 829 
        note) is amended--
                  (A) by redesignating paragraphs (1) and (2) 
                as paragraphs (2) and (3), respectively; and
                  (B) by inserting before paragraph (2), as so 
                redesignated, the following new paragraph:
          ``(1) pharmacists on how to verify the identity of 
        the patient;''.
          (3) Materials for training on patient verification 
        .--Section 3212 of the SUPPORT for Patients and 
        Communities Act (21 U.S.C. 829 note) is amended by 
        adding at the end the following new subsection:
  ``(d) Materials for Training on Verification of Identity.--
Not later than 1 year after the date of enactment of this 
subsection, the Secretary of Health and Human Services, after 
seeking stakeholder input in accordance with subsection (c), 
shall--
          ``(1) update the materials developed under subsection 
        (a) to include information for pharmacists on how to 
        verify the identity the patient; and
          ``(2) disseminate, as appropriate, the updated 
        materials.''.
  (b) Incentivizing States To Facilitate Responsible, Informed 
Dispensing of Controlled Substances.--
          (1) In general.--Section 392A of the Public Health 
        Service Act (42 U.S.C. 280b-1) is amended--
                  (A) by redesignating subsections (c) and (d) 
                as subsections (d) and (e), respectively; and
                  (B) by inserting after subsection (b) the 
                following new subsection:
  ``(c) Preference.--In determining the amounts of grants 
awarded to States under subsections (a) and (b), the Director 
of the Centers for Disease Control and Prevention may give 
preference to States in accordance with such criteria as the 
Director may specify and may choose to give preference to 
States that--
          ``(1) maintain a prescription drug monitoring 
        program;
          ``(2) require prescribers of controlled substances in 
        schedule II, III, or IV to issue such prescriptions 
        electronically, and make such requirement subject to 
        exceptions in the cases listed in section 1860D-
        4(e)(7)(B) of the Social Security Act; and
          ``(3) require dispensers of such controlled 
        substances to enter certain information about the 
        purchase of such controlled substances into the 
        respective State's prescription drug monitoring 
        program, including--
                  ``(A) the National Drug Code or, in the case 
                of compounded medications, compound identifier;
                  ``(B) the quantity dispensed;
                  ``(C) the patient identifier; and
                  ``(D) the date filled.''.
          (2) Definitions.--
                  (A) In general.--Subsection (d) of section 
                392A of the Public Health Service Act (42 
                U.S.C. 280b-1), as redesignated by paragraph 
                (1)(A), is amended to read as follows:
  ``(d) Definitions.--In this section:
          ``(1) Controlled substance.--The term `controlled 
        substance' has the meaning given that term in section 
        102 of the Controlled Substances Act.
          ``(2) Dispenser.--The term `dispenser' means a 
        physician, pharmacist, or other person that dispenses a 
        controlled substance to an ultimate user.
          ``(3) Indian tribe.--The term `Indian Tribe' has the 
        meaning given that term in section 4 of the Indian 
        Self-Determination and Education Assistance Act.''.
                  (B) Conforming change.--Section 392A of the 
                Public Health Service Act (42 U.S.C. 280b-1) is 
                amended by striking ``Indian tribes'' each 
                place it appears and inserting ``Indian 
                Tribes''.
                              ----------                              


3. An Amendment To Be Offered by Representative Dean of Pennsylvania or 
                 Her Designee, Debatable for 10 Minutes

  After section 263, insert the following new section:

SEC. 264. INCREASE IN NUMBER OF DAYS BEFORE WHICH CERTAIN CONTROLLED 
                    SUBSTANCES MUST BE ADMINISTERED.

  Section 309A(a)(5) of the Controlled Substances Act (21 
U.S.C. 829a(a)(5)) is amended by striking ``14 days'' and 
inserting ``60 days''.
                              ----------                              


 4. An Amendment To Be Offered by Representative Demings of Florida or 
                 Her Designee, Debatable for 10 Minutes

  At the end of title III, add the following new subtitle:

                      Subtitle E--Other Provisions

SEC. 341. REPORT ON LAW ENFORCEMENT MENTAL HEALTH AND WELLNESS.

  (a) In General.--Not later than 270 days after the date of 
enactment of this Act, the Attorney General, in consultation 
with the Director of the Federal Bureau of Investigation, the 
Director of the National Institute for Justice, and the 
Assistant Secretary for Mental Health and Substance Abuse, 
shall submit to the Committee on Health, Education, Labor, and 
Pensions and the Committee on the Judiciary of the Senate and 
the Committee on Energy and Commerce and the Committee on the 
Judiciary of the House of Representatives a report on--
          (1) the types, frequency, and severity of mental 
        health and stress-related responses of law enforcement 
        officers to aggressive actions or other trauma-inducing 
        incidents against law enforcement officers;
          (2) mental health and stress-related resources or 
        programs that are available to law enforcement officers 
        at the Federal, State, and local level, including peer-
        to-peer programs;
          (3) the extent to which law enforcement officers use 
        the resources or programs described in paragraph (2);
          (4) the availability of, or need for, mental health 
        screening within Federal, State, and local law 
        enforcement agencies; and
          (5) recommendations for Federal, State, and local law 
        enforcement agencies to improve the mental health and 
        wellness of their officers.
  (b) Development.--In developing the report required under 
subsection (a), the Attorney General, the Director of the 
Federal Bureau of Investigation, the Director of the National 
Institute of Justice, and the Assistant Secretary for Mental 
Health and Substance Abuse shall consult relevant stakeholders, 
including--
          (1) Federal, State, Tribal and local law enforcement 
        agencies; and
          (2) nongovernmental organizations, international 
        organizations, academies, or other entities.
                              ----------                              


5. An Amendment To Be Offered by Representative Feenstra of Iowa or His 
                   Designee, Debatable for 10 Minutes

  Page 5, after line 21, insert the following new subparagraph 
(and redesignate the subsequent subparagraphs accordingly):

                  ``(B) the Veterans Crisis Line;
                              ----------                              


6. An Amendment To Be Offered by Representative Ferguson of Georgia or 
                 His Designee, Debatable for 10 Minutes

  At the end of subtitle A of title IV, add the following new 
section:

SEC. 403. BEST PRACTICES FOR BEHAVIORAL INTERVENTION TEAMS.

  The Public Health Service Act is amended by inserting after 
section 520H of such Act, as added by section 151, the 
following new section:

``SEC. 520I. BEST PRACTICES FOR BEHAVIORAL INTERVENTION TEAMS.

  ``(a) In General.--The Secretary shall identify and 
facilitate the development of best practices to assist 
elementary schools, secondary schools, and institutions of 
higher education in establishing and using behavioral 
intervention teams.
  ``(b) Elements.--The best practices under subsection (a)(1) 
shall include guidance on the following:
          ``(1) How behavioral intervention teams can operate 
        effectively from an evidence-based, objective 
        perspective while protecting the constitutional and 
        civil rights of individuals.
          ``(2) The use of behavioral intervention teams to 
        identify concerning behaviors, implement interventions, 
        and manage risk through the framework of the school's 
        or institution's rules or code of conduct, as 
        applicable.
          ``(3) How behavioral intervention teams can, when 
        assessing an individual--
                  ``(A) access training on evidence-based, 
                threat-assessment rubrics;
                  ``(B) ensure that such teams--
                          ``(i) have trained, diverse 
                        stakeholders with varied expertise; and
                          ``(ii) use cross validation by a 
                        wide-range of individual perspectives 
                        on the team; and
                  ``(C) use violence risk assessment.
          ``(4) How behavioral intervention teams can help 
        mitigate--
                  ``(A) inappropriate use of a mental health 
                assessment;
                  ``(B) inappropriate limitations or 
                restrictions on law enforcement's jurisdiction 
                over criminal matters;
                  ``(C) attempts to substitute the behavioral 
                intervention process in place of a criminal 
                process, or impede a criminal process, when an 
                individual's behavior has potential criminal 
                implications;
                  ``(D) endangerment of an individual's privacy 
                by failing to ensure that all applicable 
                Federal and State privacy laws are fully 
                complied with; or
                  ``(E) inappropriate referrals to, or 
                involvement of, law enforcement when an 
                individual's behavior does not warrant a 
                criminal response.
  ``(c) Consultation.--In carrying out subsection (a)(1), the 
Secretary shall consult with--
          ``(1) the Secretary of Education;
          ``(2) the Director of the National Threat Assessment 
        Center of the United States Secretary Service;
          ``(3) the Attorney General and the Director of the 
        Bureau of Justice Assistance;
          ``(4) teachers and other educators, principals, 
        school administrators, school board members, school 
        psychologists, mental health professionals, and parents 
        of students;
          ``(5) local law enforcement agencies and campus law 
        enforcement administrators;
          ``(6) privacy experts; and
          ``(7) other education and mental health professionals 
        as the Secretary deems appropriate.
  ``(d) Publication.--Not later than 2 years after the date of 
enactment of this section, the Secretary shall publish the best 
practices under subsection (a)(1) on the internet website of 
the Department of Health and Human Services.
  ``(e) Technical Assistance.--The Secretary shall provide 
technical assistance to institutions of higher education, 
elementary schools, and secondary schools to assist such 
institutions and schools in implementing the best practices 
under subsection (a).
  ``(f) Definitions.--In this section:
          ``(1) The term `behavioral intervention team' means a 
        team of qualified individuals who--
                  ``(A) are responsible for identifying and 
                assessing individuals exhibiting concerning 
                behaviors, experiencing distress, or who are at 
                risk of harm to self or others;
                  ``(B) develop and facilitate implementation 
                of evidence-based interventions to mitigate the 
                threat of harm to self or others posed by an 
                individual and address the mental and 
                behavioral health needs of individuals to 
                reduce risk; and
                  ``(C) provide information to students, 
                parents, and school employees on recognizing 
                behavior described in this subsection.
          ``(2) The terms `elementary school', `parent', and 
        `secondary school' have the meanings given to such 
        terms in section 8101 of the Elementary and Secondary 
        Education Act of 1965.
          ``(3) The term `institution of higher education' has 
        the meaning given to such term in section 102 of the 
        Higher Education Act of 1965.
          ``(4) The term `mental health assessment' means an 
        evaluation, primarily focused on diagnosis, determining 
        the need for involuntary commitment, medication 
        management, and on-going treatment recommendations.
          ``(5) The term `violence risk assessment' means a 
        broad determination of the potential risk of violence 
        based on evidence-based literature.''.
                              ----------                              


   7. An Amendment To Be Offered by Representative Gottheimer of New 
            Jersey or His Designee, Debatable for 10 Minutes

  Page 9, line 22, insert ``veterans,'' after ``minorities,''.
                              ----------                              


8. An Amendment To Be Offered by Representative Griffith of Virginia or 
                 His Designee, Debatable for 10 Minutes

  Page 130, after line 3, insert the following:
  (c) Applicability.--The amendments made by this section shall 
not apply until January 1, 2024.
                              ----------                              


 9. An Amendment To Be Offered by Representative Joyce of Ohio or His 
                   Designee, Debatable for 10 Minutes

  At the end of title I, add the following new subtitle:

      Subtitle G--Military Suicide Prevention in the 21st Century

SEC. 155. PILOT PROGRAM ON PRE-PROGRAMMING OF SUICIDE PREVENTION 
                    RESOURCES INTO SMART DEVICES ISSUED TO MEMBERS OF 
                    THE ARMED FORCES.

  (a) In General.--Commencing not later than 120 days after the 
date of the enactment of this Act, the Secretary of Defense 
shall carry out a pilot program under which the Secretary--
          (1) pre-downloads the Virtual Hope Box application of 
        the Defense Health Agency, or such successor 
        application, on smart devices individually issued to 
        members of the Armed Forces;
          (2) pre-programs the National Suicide Hotline number 
        and Veterans Crisis Line number into the contacts for 
        such devices; and
          (3) provides training, as part of training on suicide 
        awareness and prevention conducted throughout the 
        Department of Defense, on the preventative resources 
        described in paragraphs (1) and (2).
  (b) Duration.--The Secretary shall carry out the pilot 
program under this section for a two-year period.
  (c) Scope.--The Secretary shall determine the appropriate 
scope of individuals participating in the pilot program under 
this section to best represent each Armed Force and to ensure a 
relevant sample size.
  (d) Identification of Other Resources.--In carrying out the 
pilot program under this section, the Secretary shall 
coordinate with the Director of the Defense Health Agency and 
the Secretary of Veterans Affairs to identify other useful 
technology-related resources for use in the pilot program.
  (e) Report.--Not later than 30 days after completing the 
pilot program under this section, the Secretary shall submit to 
the Committee on Armed Services of the Senate and the Committee 
on Armed Services of the House of Representatives a report on 
the pilot program.
  (f) Veterans Crisis Line Defined.--In this section, the term 
``Veterans Crisis Line'' means the toll-free hotline for 
veterans established under section 1720F(h) of title 38, United 
States Code.
                              ----------                              


 10. An Amendment To Be Offered by Representative Katko of New York or 
                 His Designee, Debatable for 10 Minutes

  After section 102, insert the following new section:

SEC. 103. SUICIDE PREVENTION LIFELINE IMPROVEMENT.

  (a) Suicide Prevention Lifeline.--
          (1) Plan.--Section 520E-3 of the Public Health 
        Service Act (42 U.S.C. 290bb-36c) is amended--
                  (A) by redesignating subsection (c) as 
                subsection (e); and
                  (B) by inserting after subsection (b) the 
                following:
  ``(c) Plan.--
          ``(1) In general.--For purposes of maintaining the 
        suicide prevention hotline under subsection (b)(2), the 
        Secretary shall develop and implement a plan to ensure 
        the provision of high-quality service.
          ``(2) Contents.--The plan required by paragraph (1) 
        shall include the following:
                  ``(A) Quality assurance provisions, 
                including--
                          ``(i) clearly defined and measurable 
                        performance indicators and objectives 
                        to improve the responsiveness and 
                        performance of the hotline, including 
                        at backup call centers; and
                          ``(ii) quantifiable timeframes to 
                        track the progress of the hotline in 
                        meeting such performance indicators and 
                        objectives.
                  ``(B) Standards that crisis centers and 
                backup centers must meet--
                          ``(i) to participate in the network 
                        under subsection (b)(1); and
                          ``(ii) to ensure that each telephone 
                        call, online chat message, and other 
                        communication received by the hotline, 
                        including at backup call centers, is 
                        answered in a timely manner by a 
                        person, consistent with the guidance 
                        established by the American Association 
                        of Suicidology or other guidance 
                        determined by the Secretary to be 
                        appropriate.
                  ``(C) Guidelines for crisis centers and 
                backup centers to implement evidence-based 
                practices including with respect to followup 
                and referral to other health and social 
                services resources.
                  ``(D) Guidelines to ensure that resources are 
                available and distributed to individuals using 
                the hotline who are not personally in a time of 
                crisis but know of someone who is.
                  ``(E) Guidelines to carry out periodic 
                testing of the hotline, including at crisis 
                centers and backup centers, during each fiscal 
                year to identify and correct any problems in a 
                timely manner.
                  ``(F) Guidelines to operate in consultation 
                with the State department of health, local 
                governments, Indian tribes, and tribal 
                organizations.
          ``(3) Initial plan; updates.--The Secretary shall--
                  ``(A) not later than 6 months after the date 
                of enactment of the Restoring Hope for Mental 
                Health and Well-Being Act of 2022, complete 
                development of the initial version of the plan 
                required by paragraph (1), begin implementation 
                of such plan, and make such plan publicly 
                available; and
                  ``(B) periodically thereafter, update such 
                plan and make the updated plan publicly 
                available.''.
          (2) Transmission of data to cdc.--Section 520E-3 of 
        the Public Health Service Act (42 U.S.C. 290bb-36c) is 
        amended by inserting after subsection (c) of such 
        section, as added by paragraph (1), the following:
  ``(d) Transmission of Data to CDC.--The Secretary shall 
formalize and strengthen agreements between the National 
Suicide Prevention Lifeline program and the Centers for Disease 
Control and Prevention to transmit any necessary 
epidemiological data from the program to the Centers, including 
local call center data, to assist the Centers in suicide 
prevention efforts.''.
          (3) Authorization of appropriations.--Subsection (e) 
        of section 520E-3 of the Public Health Service Act (42 
        U.S.C. 290bb-36c) is amended to read as follows:
  ``(e) Authorization of Appropriations.--
          ``(1) In general.--To carry out this section, there 
        are authorized to be appropriated $101,621,000 for each 
        of fiscal years 2023 through 2027.
          ``(2) Allocation.--Of the amount authorized to be 
        appropriated by paragraph (1) for each of fiscal years 
        2023 through 2027--
                  ``(A) at least 80 percent shall be made 
                available to crisis centers; and
                  ``(B) not more than 10 percent may be used 
                for carrying out the pilot program in section 
                103(b)(1) of the Restoring Hope for Mental 
                Health and Well-Being Act of 2022.''.
  (b) Pilot Program on Innovative Technologies.--
          (1) In general.--The Secretary of Health and Human 
        Services, acting through the Assistant Secretary for 
        Mental Health and Substance Use, shall carry out a 
        pilot program to research, analyze, and employ various 
        technologies and platforms of communication (including 
        social media platforms, texting platforms, and email 
        platforms) for suicide prevention in addition to the 
        telephone and online chat service provided by the 
        Suicide Prevention Lifeline.
          (2) Report.--Not later than 24 months after the date 
        on which the pilot program under paragraph (1) 
        commences, the Secretary of Health and Human Services, 
        acting through the Assistant Secretary for Mental 
        Health and Substance Use, shall submit to the Congress 
        a report on the pilot program. With respect to each 
        platform of communication employed pursuant to the 
        pilot program, the report shall include--
                  (A) a full description of the program;
                  (B) the number of individuals served by the 
                program;
                  (C) the average wait time for each individual 
                to receive a response;
                  (D) the cost of the program, including the 
                cost per individual served; and
                  (E) any other information the Secretary 
                determines appropriate.
  (c) HHS Study and Report.--Not later than 24 months after the 
Secretary of Health and Human Services begins implementation of 
the plan required by section 520E-3(c) of the Public Health 
Service Act, as added by subsection (a)(1)(B), the Secretary 
shall--
          (1) complete a study on--
                  (A) the implementation of such plan, 
                including the progress towards meeting the 
                objectives identified pursuant to paragraph 
                (2)(A)(i) of such section 520E-3(c) by the 
                timeframes identified pursuant to paragraph 
                (2)(A)(ii) of such section 520E-3(c); and
                  (B) in consultation with the Director of the 
                Centers for Disease Control and Prevention, 
                options to expand data gathering from calls to 
                the Suicide Prevention Lifeline in order to 
                better track aspects of usage such as repeat 
                calls, consistent with applicable Federal and 
                State privacy laws; and
          (2) submit a report to the Congress on the results of 
        such study, including recommendations on whether 
        additional legislation or appropriations are needed.
  (d) GAO Study and Report.--
          (1) In general.--Not later than 24 months after the 
        Secretary of Health and Human Services begins 
        implementation of the plan required by section 520E-
        3(c) of the Public Health Service Act, as added by 
        subsection (a)(1)(B), the Comptroller General of the 
        United States shall--
                  (A) complete a study on the Suicide 
                Prevention Lifeline; and
                  (B) submit a report to the Congress on the 
                results of such study.
          (2) Issues to be studied.--The study required by 
        paragraph (1) shall address--
                  (A) the feasibility of geolocating callers to 
                direct calls to the nearest crisis center;
                  (B) operation shortcomings of the Suicide 
                Prevention Lifeline;
                  (C) geographic coverage of each crisis call 
                center;
                  (D) the call answer rate of each crisis call 
                center;
                  (E) the call wait time of each crisis call 
                center;
                  (F) the hours of operation of each crisis 
                call center;
                  (G) funding avenues of each crisis call 
                center;
                  (H) the implementation of the plan under 
                section 520E-3(c) of the Public Health Service 
                Act, as added by subsection (a)(1)(B), 
                including the progress towards meeting the 
                objectives identified pursuant to paragraph 
                (2)(A)(i) of such section 520E-3(c) by the 
                timeframes identified pursuant to paragraph 
                (2)(A)(ii) of such section 520E-3(c); and
                  (I) service to individuals requesting a 
                foreign language speaker, including--
                          (i) the number of calls or chats the 
                        Lifeline receives from individuals 
                        speaking a foreign language;
                          (ii) the capacity of the Lifeline to 
                        handle these calls or chats; and
                          (iii) the number of crisis centers 
                        with the capacity to serve foreign 
                        language speakers, in house.
          (3) Recommendations.--The report required by 
        paragraph (1) shall include recommendations for 
        improving the Suicide Prevention Lifeline, including 
        recommendations for legislative and administrative 
        actions.
  (e) Definition.--In this section, the term ``Suicide 
Prevention Lifeline'' means the suicide prevention hotline 
maintained pursuant to section 520E-3 of the Public Health 
Service Act (42 U.S.C. 290bb-36c).
                              ----------                              


 11. An Amendment To Be Offered by Representative Kim of New Jersey or 
                 His Designee, Debatable for 10 Minutes

  At the end of title II, add the following new subtitle:

                  Subtitle G--Opioid Epidemic Response

SEC. 271. SYNTHETIC OPIOID DANGER AWARENESS.

  (a) Synthetic Opioids Public Awareness Campaign.--Part B of 
title III of the Public Health Service Act is amended by 
inserting after section 317U (42 U.S.C. 247b-23) the following 
new section:

``SEC. 317V. SYNTHETIC OPIOIDS PUBLIC AWARENESS CAMPAIGN.

  ``(a) In General.--Not later than one year after the date of 
the enactment of this section, the Secretary shall provide for 
the planning and implementation of a public education campaign 
to raise public awareness of synthetic opioids (including 
fentanyl and its analogues). Such campaign shall include the 
dissemination of information that--
          ``(1) promotes awareness about the potency and 
        dangers of fentanyl and its analogues and other 
        synthetic opioids;
          ``(2) explains services provided by the Substance 
        Abuse and Mental Health Services Administration and the 
        Centers for Disease Control and Prevention (and any 
        entity providing such services under a contract entered 
        into with such agencies) with respect to the misuse of 
        opioids, particularly as such services relate to the 
        provision of alternative, non-opioid pain management 
        treatments; and
          ``(3) relates generally to opioid use and pain 
        management.
  ``(b) Use of Media.--The campaign under subsection (a) may be 
implemented through the use of television, radio, internet, in-
person public communications, and other commercial marketing 
venues and may be targeted to specific age groups.
  ``(c) Consideration of Report Findings.--In planning and 
implementing the public education campaign under subsection 
(a), the Secretary shall take into consideration the findings 
of the report required under section 7001 of the SUPPORT for 
Patients and Communities Act (Public Law 115-271).
  ``(d) Consultation.--In coordinating the campaign under 
subsection (a), the Secretary shall consult with the Assistant 
Secretary for Mental Health and Substance Use to provide 
ongoing advice on the effectiveness of information disseminated 
through the campaign.
  ``(e) Requirement of Campaign.--The campaign implemented 
under subsection (a) shall not be duplicative of any other 
Federal efforts relating to eliminating the misuse of opioids.
  ``(f) Evaluation.--
          ``(1) In general.--The Secretary shall ensure that 
        the campaign implemented under subsection (a) is 
        subject to an independent evaluation, beginning 2 years 
        after the date of the enactment of this section, and 
        every 2 years thereafter.
          ``(2) Measures and benchmarks.--For purposes of an 
        evaluation conducted pursuant to paragraph (1), the 
        Secretary shall--
                  ``(A) establish baseline measures and 
                benchmarks to quantitatively evaluate the 
                impact of the campaign under this section; and
                  ``(B) conduct qualitative assessments 
                regarding the effectiveness of strategies 
                employed under this section.
  ``(g) Report.--The Secretary shall, beginning 2 years after 
the date of the enactment of this section, and every 2 years 
thereafter, submit to Congress a report on the effectiveness of 
the campaign implemented under subsection (a) towards meeting 
the measures and benchmarks established under subsection 
(e)(2).
  ``(h) Dissemination of Information Through Providers.--The 
Secretary shall develop and implement a plan for the 
dissemination of information related to synthetic opioids, to 
health care providers who participate in Federal programs, 
including programs administered by the Department of Health and 
Human Services, the Indian Health Service, the Department of 
Veterans Affairs, the Department of Defense, and the Health 
Resources and Services Administration, the Medicare program 
under title XVIII of the Social Security Act, and the Medicaid 
program under title XIX of such Act.''.
  (b) Training Guide and Outreach on Synthetic Opioid Exposure 
Prevention.--
          (1) Training guide.--Not later than 18 months after 
        the date of the enactment of this Act, the Secretary of 
        Health and Human Services shall design, publish, and 
        make publicly available on the internet website of the 
        Department of Health and Human Services, a training 
        guide and webinar for first responders and other 
        individuals who also may be at high risk of exposure to 
        synthetic opioids that details measures to prevent that 
        exposure.
          (2) Outreach.--Not later than 18 months after the 
        date of the enactment of this Act, the Secretary of 
        Health and Human Services shall also conduct outreach 
        about the availability of the training guide and 
        webinar published under paragraph (1) to--
                  (A) police and fire managements;
                  (B) sheriff deputies in city and county 
                jails;
                  (C) ambulance transport and hospital 
                emergency room personnel;
                  (D) clinicians; and
                  (E) other high-risk occupations, as 
                identified by the Assistant Secretary for 
                Mental Health and Substance Use.
                              ----------                              


   12. An Amendment To Be Offered by Representative McKinley of West 
           Virginia or His Designee, Debatable for 10 Minutes

  After section 263, insert the following new section:

SEC. 264. BLOCK, REPORT, AND SUSPEND SUSPICIOUS SHIPMENTS.

  (a) Clarification of Process for Registrants to Exercise Due 
Diligence Upon Discovering a Suspicious Order.--Paragraph (3) 
of section 312(a) of the Controlled Substances Act (21 U.S.C. 
832(a)) is amended to read as follows:
          ``(3) upon discovering a suspicious order or series 
        of orders, and in a manner consistent with the other 
        requirements of this section--
                  ``(A) exercise due diligence as appropriate;
                  ``(B) establish and maintain (for not less 
                than a period to be determined by the 
                Administrator of the Drug Enforcement 
                Administration) a record of the due diligence 
                that was performed;
                  ``(C) decline to fill the order or series of 
                orders if the due diligence fails to dispel all 
                of the indicators that give rise to the 
                suspicion that, if the order or series of 
                orders is filled, the drugs that are the 
                subject of the order or series of orders are 
                likely to be diverted; and
                  ``(D) notify the Administrator of the Drug 
                Enforcement Administration and the Special 
                Agent in Charge of the Division Office of the 
                Drug Enforcement Administration for the area in 
                which the registrant is located or conducts 
                business of--
                          ``(i) each suspicious order or series 
                        of orders discovered by the registrant; 
                        and
                          ``(ii) the indicators giving rise to 
                        the suspicion that, if the order or 
                        series of orders is filled, the drugs 
                        that are the subject of the order or 
                        series of orders are likely to be 
                        diverted.''.
  (b) Resolution of Suspicious Indicators.--Section 312 of the 
Controlled Substances Act (21 U.S.C. 832) is amended--
          (1) by redesignating subsection (b) and (c) as 
        subsections (c) and (d), respectively; and
          (2) by inserting after subsection (a) the following:
  ``(b) Resolution of Suspicious Indicators.--If a registrant 
resolves all of the indicators giving rise to suspicion about 
an order or series of orders under subsection (a)(3)--
          ``(1) notwithstanding subsection (a)(3)(C), the 
        registrant may choose to fill the order or series of 
        orders; and
          ``(2) notwithstanding subsection (a)(3)(D), the 
        registrant may choose not to make the notification 
        otherwise required by such subsection.''.
  (c) Regulations.--Not later than 1 year after the date of 
enactment of this Act, for purposes of subsections (a)(3) and 
(b) of section 312 of the Controlled Substances Act, as amended 
or inserted by subsection (a), the Attorney General of the 
United States shall promulgate a final regulation specifying 
the indicators that give rise to a suspicion that, if an order 
or series of orders is filled, the drugs that are the subject 
of the order or series of orders are likely to be diverted.
  (d) Applicability.--Subsections (a)(3) and (b) of section 312 
of the Controlled Substances Act, as amended or inserted by 
subsection (a), shall apply beginning on the day that is 1 year 
after the date of enactment of this Act. Until such day, 
section 312(a)(3) of the Controlled Substances Act shall apply 
as such section 312(a)(3) was in effect on the day before the 
date of enactment of this Act.
                              ----------                              


13. An Amendment To Be Offered by Representative Moore of Wisconsin or 
                 Her Designee, Debatable for 10 Minutes

  Page 20, line 4, strike ``and''.
  Page 20, line 9, strike the period at the end and insert ``; 
and''.
  Page 20, after line 9, add the following:
          ``(4) consult with appropriate State, local, and 
        Tribal public health officials, including officials 
        that administer programs that serve low-income pregnant 
        and postpartum individuals.''.
                              ----------                              


    14. An Amendment To Be Offered by Representative Napolitano of 
          California or Her Designee, Debatable for 10 Minutes

  After section 402, insert the following new section:

SEC. 403. SCHOOL-BASED MENTAL HEALTH; CHILDREN AND ADOLESCENTS.

  (a) Technical Amendments.--The second part G (relating to 
services provided through religious organizations) of title V 
of the Public Health Service Act (42 U.S.C. 290kk et seq.) is 
amended--
          (1) by redesignating such part as part J; and
          (2) by redesignating sections 581 through 584 as 
        sections 596 through 596C, respectively.
  (b) School-Based Mental Health and Children.--Section 581 of 
the Public Health Service Act (42 U.S.C. 290hh) (relating to 
children and violence) is amended to read as follows:

``SEC. 581. SCHOOL-BASED MENTAL HEALTH; CHILDREN AND ADOLESCENTS.

  ``(a) In General.--The Secretary, in consultation with the 
Secretary of Education, shall, through grants, contracts, or 
cooperative agreements awarded to eligible entities described 
in subsection (c), provide comprehensive school-based mental 
health services and supports to assist children in local 
communities and schools (including schools funded by the Bureau 
of Indian Education) dealing with traumatic experiences, grief, 
bereavement, risk of suicide, and violence. Such services and 
supports shall be--
          ``(1) developmentally, linguistically, and culturally 
        appropriate;
          ``(2) trauma-informed; and
          ``(3) incorporate positive behavioral interventions 
        and supports.
  ``(b) Activities.--Grants, contracts, or cooperative 
agreements awarded under subsection (a), shall, as appropriate, 
be used for--
          ``(1) implementation of school and community-based 
        mental health programs that--
                  ``(A) build awareness of individual trauma 
                and the intergenerational, continuum of impacts 
                of trauma on populations;
                  ``(B) train appropriate staff to identify, 
                and screen for, signs of trauma exposure, 
                mental health disorders, or risk of suicide; 
                and
                  ``(C) incorporate positive behavioral 
                interventions, family engagement, student 
                treatment, and multigenerational supports to 
                foster the health and development of children, 
                prevent mental health disorders, and ameliorate 
                the impact of trauma;
          ``(2) technical assistance to local communities with 
        respect to the development of programs described in 
        paragraph (1);
          ``(3) facilitating community partnerships among 
        families, students, law enforcement agencies, education 
        agencies, mental health and substance use disorder 
        service systems, family-based mental health service 
        systems, child welfare agencies, health care providers 
        (including primary care physicians, mental health 
        professionals, and other professionals who specialize 
        in children's mental health such as child and 
        adolescent psychiatrists), institutions of higher 
        education, faith-based programs, trauma networks, and 
        other community-based systems to address child and 
        adolescent trauma, mental health issues, and violence; 
        and
          ``(4) establishing mechanisms for children and 
        adolescents to report incidents of violence or plans by 
        other children, adolescents, or adults to commit 
        violence.
  ``(c) Requirements.--
          ``(1) In general.--To be eligible for a grant, 
        contract, or cooperative agreement under subsection 
        (a), an entity shall be a partnership that includes--
                  ``(A) a State educational agency, as defined 
                in section 8101 of the Elementary and Secondary 
                Education Act of 1965, in coordination with one 
                or more local educational agencies, as defined 
                in section 8101 of the Elementary and Secondary 
                Education Act of 1965, or a consortium of any 
                entities described in subparagraph (B), (C), 
                (D), or (E) of section 8101(30) of such Act; 
                and
                  ``(B) at least 1 community-based mental 
                health provider, including a public or private 
                mental health entity, health care entity, 
                family-based mental health entity, trauma 
                network, or other community-based entity, as 
                determined by the Secretary (and which may 
                include additional entities such as a human 
                services agency, law enforcement or juvenile 
                justice entity, child welfare agency, agency, 
                an institution of higher education, or another 
                entity, as determined by the Secretary).
          ``(2) Compliance with hipaa.--Any patient records 
        developed by covered entities through activities under 
        the grant shall meet the regulations promulgated under 
        section 264(c) of the Health Insurance Portability and 
        Accountability Act of 1996.
          ``(3) Compliance with ferpa.--Section 444 of the 
        General Education Provisions Act (commonly known as the 
        `Family Educational Rights and Privacy Act of 1974') 
        shall apply to any entity that is a member of the 
        partnership in the same manner that such section 
        applies to an educational agency or institution (as 
        that term is defined in such section).
  ``(d) Geographical Distribution.--The Secretary shall ensure 
that grants, contracts, or cooperative agreements under 
subsection (a) will be distributed equitably among the regions 
of the country and among urban and rural areas.
  ``(e) Duration of Awards.--With respect to a grant, contract, 
or cooperative agreement under subsection (a), the period 
during which payments under such an award will be made to the 
recipient shall be 5 years, with options for renewal.
  ``(f) Evaluation and Measures of Outcomes.--
          ``(1) Development of process.--The Assistant 
        Secretary shall develop a fiscally appropriate process 
        for evaluating activities carried out under this 
        section. Such process shall include--
                  ``(A) the development of guidelines for the 
                submission of program data by grant, contract, 
                or cooperative agreement recipients;
                  ``(B) the development of measures of outcomes 
                (in accordance with paragraph (2)) to be 
                applied by such recipients in evaluating 
                programs carried out under this section; and
                  ``(C) the submission of annual reports by 
                such recipients concerning the effectiveness of 
                programs carried out under this section.
          ``(2) Measures of outcomes.--The Assistant Secretary 
        shall develop measures of outcomes to be applied by 
        recipients of assistance under this section to evaluate 
        the effectiveness of programs carried out under this 
        section, including outcomes related to the student, 
        family, and local educational systems supported by this 
        Act.
          ``(3) Submission of annual data.--An eligible entity 
        described in subsection (c) that receives a grant, 
        contract, or cooperative agreement under this section 
        shall annually submit to the Assistant Secretary a 
        report that includes data to evaluate the success of 
        the program carried out by the entity based on whether 
        such program is achieving the purposes of the program. 
        Such reports shall utilize the measures of outcomes 
        under paragraph (2) in a reasonable manner to 
        demonstrate the progress of the program in achieving 
        such purposes.
          ``(4) Evaluation by assistant secretary.--Based on 
        the data submitted under paragraph (3), the Assistant 
        Secretary shall annually submit to Congress a report 
        concerning the results and effectiveness of the 
        programs carried out with assistance received under 
        this section.
          ``(5) Limitation.--An eligible entity shall use not 
        more than 20 percent of amounts received under a grant 
        under this section to carry out evaluation activities 
        under this subsection.
  ``(g) Information and Education.--The Secretary shall 
disseminate best practices based on the findings of the 
knowledge development and application under this section.
  ``(h) Amount of Grants and Authorization of Appropriations.--
          ``(1) Amount of grants.--A grant under this section 
        shall be in an amount that is not more than $2,000,000 
        for each of the first 5 fiscal years following the date 
        of enactment of the Restoring Hope for Mental Health 
        and Well-Being Act of 2022. The Secretary shall 
        determine the amount of each such grant based on the 
        population of children up to age 21 of the area to be 
        served under the grant.
          ``(2) Authorization of appropriations.--There is 
        authorized to be appropriated to carry out this 
        section, $130,000,000 for each of fiscal years 2023 
        through 2027.''.
  (c) Conforming Amendment.--Part G of title V of the Public 
Health Service Act (42 U.S.C. 290hh et seq.), as amended by 
subsection (b), is further amended by striking the part 
designation and heading and inserting the following:

                ``PART G--SCHOOL-BASED MENTAL HEALTH''.

                              ----------                              


     15. An Amendment To Be Offered by Representative Pressley of 
        Massachusetts or Her Designee, Debatable for 10 Minutes

  After section 402, insert the following new section:

SEC. 403. CO-OCCURRING CHRONIC CONDITIONS AND MENTAL HEALTH IN YOUTH 
                    STUDY.

  Not later than 12 months after the date of enactment of this 
Act, the Secretary of Health and Human Services shall--
          (1) complete a study on the rates of suicidal 
        behaviors among children and adolescents with chronic 
        illnesses, including substance use disorders, 
        autoimmune disorders, and heritable blood disorders; 
        and
          (2) submit a report to the Congress on the results of 
        such study, including recommendations for early 
        intervention services for such children and adolescents 
        at risk of suicide, the dissemination of best practices 
        to support the emotional and mental health needs of 
        youth, and strategies to lower the rates of suicidal 
        behaviors in children and adolescents described in 
        paragraph (1) to reduce any demographic disparities in 
        such rates.
                              ----------                              


   16. An Amendment To Be Offered by Representative Reschenthaler of 
         Pennsylvania or His Designee, Debatable for 10 Minutes

  At the end of subtitle C of title I, add the following new 
section:

SEC. 124. STUDY ON THE COSTS OF SERIOUS MENTAL ILLNESS.

  (a) In General.--The Secretary of Health and Human Services, 
in consultation with the Assistant Secretary for Mental Health 
and Substance Use, the Assistant Secretary for Planning and 
Evaluation, the Attorney General of the United States, the 
Secretary of Labor, and the Secretary of Housing and Urban 
Development, shall conduct a study on the direct and indirect 
costs of serious mental illness with respect to--
          (1) nongovernmental entities; and
          (2) the Federal Government and State, local, and 
        Tribal governments.
  (b) Content.--The study under subsection (a) shall consider 
each of the following:
          (1) The costs to the health care system for health 
        services, including with respect to--
                  (A) office-based physician visits;
                  (B) residential and inpatient treatment 
                programs;
                  (C) outpatient treatment programs;
                  (D) emergency room visits;
                  (E) crisis stabilization programs;
                  (F) home health care;
                  (G) skilled nursing and long-term care 
                facilities;
                  (H) prescription drugs and digital 
                therapeutics; and
                  (I) any other relevant health services.
          (2) The costs of homelessness, including with respect 
        to--
                  (A) homeless shelters;
                  (B) street outreach activities;
                  (C) crisis response center visits; and
                  (D) other supportive services.
          (3) The costs of structured residential facilities 
        and other supportive housing for residential and 
        custodial care services.
          (4) The costs of law enforcement encounters and 
        encounters with the criminal justice system, including 
        with respect to--
                  (A) encounters that do and do not result in 
                an arrest;
                  (B) criminal and judicial proceedings;
                  (C) services provided by law enforcement and 
                judicial staff (including public defenders, 
                prosecutors, and private attorneys); and
                  (D) incarceration.
          (5) The costs of serious mental illness on 
        employment.
          (6) With respect to family members and caregivers, 
        the costs of caring for an individual with a serious 
        mental illness.
          (7) Any other relevant costs for programs and 
        services administered by the Federal Government or 
        State, Tribal, or local governments.
  (c) Data Disaggregation.--In conducting the study under 
subsection (a), the Secretary of Health and Human Services 
shall (to the extent feasible)--
          (1) disaggregate data by--
                  (A) costs to nongovernmental entities, the 
                Federal Government, and State, local, and 
                Tribal governments;
                  (B) types of serious mental illnesses and 
                medical chronic diseases common in patients 
                with a serious mental illness; and
                  (C) demographic characteristics, including 
                race, ethnicity, sex, age (including pediatric 
                subgroups), and other characteristics 
                determined by the Secretary; and
          (2) include an estimate of--
                  (A) the total number of individuals with a 
                serious mental illness in the United States, 
                including in traditional and nontraditional 
                housing; and
                  (B) the percentage of such individuals in--
                          (i) homeless shelters;
                          (ii) penal facilities, including 
                        Federal prisons, State prisons, and 
                        county and municipal jails; and
                          (iii) nursing facilities.
  (d) Report.--Not later than 2 years after the date of the 
enactment of this Act, the Secretary of Health and Human 
Services shall--
          (1) submit to the Congress a report containing the 
        results of the study conducted under this section; and
          (2) make such report publicly available.
                              ----------                              


 17. An Amendment To Be Offered by Representative Trone of Maryland or 
                 His Designee, Debatable for 10 Minutes

  At the end of title II, add the following new subtitle:

                  Subtitle I--Opioid Epidemic Response

SEC. 271. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO OPIOID AND 
                    STIMULANT USE AND MISUSE.

  Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee-3 
note) is amended to read as follows:

``SEC. 1003. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO OPIOID AND 
                    STIMULANT USE AND MISUSE.

  ``(a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the `Secretary') shall carry 
out the grant program described in subsection (b) for purposes 
of addressing opioid and stimulant use and misuse, within 
States, Indian Tribes, and populations served by Tribal 
organizations and Urban Indian organizations.
  ``(b) Grants Program.--
          ``(1) In general.--Subject to the availability of 
        appropriations, the Secretary shall award grants to 
        States, Indian Tribes, Tribal organizations, and Urban 
        Indian organizations for the purpose of addressing 
        opioid and stimulant use and misuse, within such 
        States, such Indian Tribes, and populations served by 
        such Tribal organizations and Urban Indian 
        organizations, in accordance with paragraph (2).
          ``(2) Minimum allocations; preference.--In 
        determining grant amounts for each recipient of a grant 
        under paragraph (1), the Secretary shall--
                  ``(A) ensure that each State receives not 
                less than $4,000,000; and
                  ``(B) give preference to States, Indian 
                Tribes, Tribal organizations, and Urban Indian 
                organizations whose populations have an 
                incidence or prevalence of opioid use disorders 
                or stimulant use or misuse that is 
                substantially higher relative to the 
                populations of other States, other Indian 
                Tribes, Tribal organizations, or Urban Indian 
                organizations, as applicable.
          ``(3) Formula methodology.--
                  ``(A) In general.--Before publishing a 
                funding opportunity announcement with respect 
                to grants under this section, the Secretary 
                shall--
                          ``(i) develop a formula methodology 
                        to be followed in allocating grant 
                        funds awarded under this section among 
                        grantees, which includes performance 
                        assessments for continuation awards; 
                        and
                          ``(ii) not later than 30 days after 
                        developing the formula methodology 
                        under clause (i), submit the formula 
                        methodology to--
                                  ``(I) the Committee on Energy 
                                and Commerce and the Committee 
                                on Appropriations of the House 
                                of Representatives; and
                                  ``(II) the Committee on 
                                Health, Education, Labor, and 
                                Pensions and the Committee on 
                                Appropriations of the Senate.
                  ``(B) Report.--Not later than two years after 
                the date of the enactment of the Restoring Hope 
                for Mental Health and Well-Being Act of 2022, 
                the Comptroller General of the United States 
                shall submit to the Committee on Health, 
                Education, Labor, and Pensions of the Senate 
                and the Committee on Energy and Commerce of the 
                House of Representatives a report that--
                          ``(i) assesses how grant funding is 
                        allocated to States under this section 
                        and how such allocations have changed 
                        over time;
                          ``(ii) assesses how any changes in 
                        funding under this section have 
                        affected the efforts of States to 
                        address opioid or stimulant use or 
                        misuse; and
                          ``(iii) assesses the use of funding 
                        provided through the grant program 
                        under this section and other similar 
                        grant programs administered by the 
                        Substance Abuse and Mental Health 
                        Services Administration.
          ``(4) Use of funds.--Grants awarded under this 
        subsection shall be used for carrying out activities 
        that supplement activities pertaining to opioid and 
        stimulant use and misuse, undertaken by the State 
        agency responsible for administering the substance 
        abuse prevention and treatment block grant under 
        subpart II of part B of title XIX of the Public Health 
        Service Act (42 U.S.C. 300x-21 et seq.), which may 
        include public health-related activities such as the 
        following:
                  ``(A) Implementing prevention activities, and 
                evaluating such activities to identify 
                effective strategies to prevent substance use 
                disorders.
                  ``(B) Establishing or improving prescription 
                drug monitoring programs.
                  ``(C) Training for health care practitioners, 
                such as best practices for prescribing opioids, 
                pain management, recognizing potential cases of 
                substance use disorders, referral of patients 
                to treatment programs, preventing diversion of 
                controlled substances, and overdose prevention.
                  ``(D) Supporting access to health care 
                services, including--
                          ``(i) services provided by federally 
                        certified opioid treatment programs;
                          ``(ii) outpatient and residential 
                        substance use disorder treatment 
                        services that utilize medication-
                        assisted treatment, as appropriate; or
                          ``(iii) other appropriate health care 
                        providers to treat substance use 
                        disorders.
                  ``(E) Recovery support services, including--
                          ``(i) community-based services that 
                        include peer supports;
                          ``(ii) mutual aid recovery programs 
                        that support medication-assisted 
                        treatment; or
                          ``(iii) services to address housing 
                        needs and family issues.
                  ``(F) Other public health-related activities, 
                as the State, Indian Tribe, Tribal 
                organization, or Urban Indian organization 
                determines appropriate, related to addressing 
                substance use disorders within the State, 
                Indian Tribe, Tribal organization, or Urban 
                Indian organization, including directing 
                resources in accordance with local needs 
                related to substance use disorders.
  ``(c) Accountability and Oversight.--A State receiving a 
grant under subsection (b) shall include in reporting related 
to substance use disorders submitted to the Secretary pursuant 
to section 1942 of the Public Health Service Act (42 U.S.C. 
300x-52), a description of--
          ``(1) the purposes for which the grant funds received 
        by the State under such subsection for the preceding 
        fiscal year were expended and a description of the 
        activities of the State under the grant;
          ``(2) the ultimate recipients of amounts provided to 
        the State; and
          ``(3) the number of individuals served through the 
        grant.
  ``(d) Limitations.--Any funds made available pursuant to 
subsection (i)--
          ``(1) shall not be used for any purpose other than 
        the grant program under subsection (b); and
          ``(2) shall be subject to the same requirements as 
        substance use disorders prevention and treatment 
        programs under titles V and XIX of the Public Health 
        Service Act (42 U.S.C. 290aa et seq., 300w et seq.).
  ``(e) Indian Tribes, Tribal Organizations, and Urban Indian 
Organizations.--The Secretary, in consultation with Indian 
Tribes, Tribal organizations, and Urban Indian organizations, 
shall identify and establish appropriate mechanisms for Indian 
Tribes, Tribal organizations, and Urban Indian organizations to 
demonstrate or report the information as required under 
subsections (b), (c), and (d).
  ``(f) Report to Congress.--Not later than September 30, 2024, 
and biennially thereafter, the Secretary shall submit to the 
Committee on Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Commerce of the House of 
Representatives, and the Committees on Appropriations of the 
House of Representatives and the Senate, a report that includes 
a summary of the information provided to the Secretary in 
reports made pursuant to subsections (c) and (e), including--
          ``(1) the purposes for which grant funds are awarded 
        under this section;
          ``(2) the activities of the grant recipients; and
          ``(3) for each State, Indian Tribe, Tribal 
        organization, and Urban Indian organization that 
        receives a grant under this section, the funding level 
        provided to such recipient.
  ``(g) Technical Assistance.--The Secretary, including through 
the Tribal Training and Technical Assistance Center of the 
Substance Abuse and Mental Health Services Administration, 
shall provide States, Indian Tribes, Tribal organizations, and 
Urban Indian organizations, as applicable, with technical 
assistance concerning grant application and submission 
procedures under this section, award management activities, and 
enhancing outreach and direct support to rural and underserved 
communities and providers in addressing substance use 
disorders.
  ``(h) Definitions.--In this section:
          ``(1) Indian tribe.--The term `Indian Tribe' has the 
        meaning given the term `Indian tribe' in section 4 of 
        the Indian Self-Determination and Education Assistance 
        Act (25 U.S.C. 5304).
          ``(2) Tribal organization.--The term `Tribal 
        organization' has the meaning given the term `tribal 
        organization' in such section 4.
          ``(3) State.--The term `State' has the meaning given 
        such term in section 1954(b) of the Public Health 
        Service Act (42 U.S.C. 300x-64(b)).
          ``(4) Urban indian organization.--The term `Urban 
        Indian organization' has the meaning given such term in 
        section 4 of the Indian Health Care Improvement Act.
  ``(i) Authorization of Appropriations.--
          ``(1) In general.--For purposes of carrying out the 
        grant program under subsection (b), there is authorized 
        to be appropriated $1,750,000,000 for each of fiscal 
        years 2023 through 2027, to remain available until 
        expended.
          ``(2) Federal administrative expenses.--Of the 
        amounts made available for each fiscal year to award 
        grants under subsection (b), the Secretary shall not 
        use more than 20 percent for Federal administrative 
        expenses, training, technical assistance, and 
        evaluation.
          ``(3) Set aside.--Of the amounts made available for 
        each fiscal year to award grants under subsection (b) 
        for a fiscal year, the Secretary shall--
                  ``(A) award 5 percent to Indian Tribes, 
                Tribal organizations, and Urban Indian 
                organizations; and
                  ``(B) of the amount remaining after 
                application of subparagraph (A), set aside up 
                to 15 percent for awards to States with the 
                highest age-adjusted rate of drug overdose 
                death based on the ordinal ranking of States 
                according to the Director of the Centers for 
                Disease Control and Prevention.''.

                                  
                                  
                                  [all]